Processing 00000000.tx.1: Tubulin Seeds -Synuclein Fibril Formation* Muhammad Abdul Alim, Mosammat Shahanara Hossain, Kunimasa Arima, Kazuya Takeda**, Yoko Izumiyama, Minako Nakamura, Hiroyuki Kaji, Tomotaka Shinoda, Shinichi Hisanaga, and Kenji Uda From the Departments of Neural Plasticity and of Ultrastructure &Histochemistry, and Electron Microscopy Center, Tokyo Institute of Psychiatry, Setagaya-ku, Tokyo 156-8585,Japan, Departments of Chemistry and Biology, Graduate School of Science, Tokyo Metropolitan University, Hachioji, Tokyo 192-0364,Japan Received for publication, April 4,2001, and in revised form, November 2,2001  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Increasing evidence suggests that -synuclein is a common pathogenic molecule in several neurodegenerative diseases, particularly in Parkinson's disease. 

Phrase: "Tubulin Seeds -Synuclein Fibril Formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]

Phrase: "* Muhammad Abdul Alim,"

Phrase: "Mosammat Shahanara Hossain,"

Phrase: "Kunimasa Arima,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1563875:Arima [Organic Chemical,Pharmacologic Substance]

Phrase: "Kazuya Takeda"

Phrase: "*"

Phrase: "*,"

Phrase: "Yoko Izumiyama,"

Phrase: "Minako Nakamura,"

Phrase: "Hiroyuki Kaji,"

Phrase: "Tomotaka Shinoda,"

Phrase: "Shinichi Hisanaga,"

Phrase: "and"

Phrase: "Kenji Uda From the Departments of Neural Plasticity"

Phrase: "and of Ultrastructure &Histochemistry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0019635:Histochemistry [Laboratory Procedure]
   770   C0041623:Ultrastructure [Idea or Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "Electron Microscopy Center,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205099:Center [Spatial Concept]
   734   C0026019:Electron Microscopy [Laboratory Procedure]
   734   C2984656:ELECTRON MICROSCOPY [Functional Concept]

Phrase: "Tokyo Institute of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Setagaya-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 156-8585,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Departments of Chemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Biology,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005532:Biology [Biomedical Occupation or Discipline]
   928 E C0205460:Biologic [Qualitative Concept]
   928 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Graduate School of Science,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870614:graduate school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]
   770   C0588053:Graduate [Population Group]
   770   C1547183:Graduate [Idea or Concept]

Phrase: "Tokyo Metropolitan University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Hachioji,"

Phrase: "Tokyo 192-0364,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "April 4,"

Phrase: "2001,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "November 2,"

Phrase: "2001  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1514811:Reference [Idea or Concept]
   756   C1706462:Reference [Conceptual Entity]

Phrase: "Increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a common pathogenic molecule in several neurodegenerative diseases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0567416:Molecule [Substance]
   714   C0019247:Molecular Disease [Disease or Syndrome]

Phrase: "particularly in Parkinson's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.2: To understand -synuclein pathology, we investigated molecules that interact with -synuclein in human and rat brains and identified tubulin as an -synuclein binding/associated protein. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "understand -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "synuclein pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "interact with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rat brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "identified tubulin as an -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2937342:tubulin [Cell Component]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "/associated protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.3: Tubulin co-localized with -synuclein in Lewy bodies and other -synuclein-positive pathological structures. 

Phrase: "Tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "co-localized with -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392752:Localized [Spatial Concept]

Phrase: "in Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "other -synuclein-positive pathological structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:structures [Spatial Concept]
Processing 00000000.tx.4: Tubulin initiated and promoted -synuclein fibril formation under physiological conditions in vitro. 

Phrase: "Tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "and"

Phrase: "promoted -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "synuclein fibril formation under physiological conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.5: These findings suggest that an interaction between tubulin and -synuclein might accelerate -synuclein aggregation in diseased brains, leading to the formation of Lewy bodies.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "an interaction between tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C3537022:Tubulin Interaction [Molecular Function]
   770   C1704675:Interaction [Functional Concept]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "accelerate -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "synuclein aggregation in diseased brains,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "leading to the formation of Lewy bodies."
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0220781:formation [Biologic Function]
   748   C0242821:bodies [Human]
   748   C0332152:Leading [Temporal Concept]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1522538:Leading [Functional Concept]
   748   C1995017:Bodies [Cell Component]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.6: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The non--amyloid (A)1 component of Alzheimer's disease amyloid, or NAC, originally detected in an amyloid-enriched fraction, was shown to be a fragment of its precursor, NACP, by cloning of the full-length cDNA (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The non--amyloid (A)1 component of Alzheimer's disease amyloid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]

Phrase: "or"

Phrase: "NAC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538756:NAC [Gene or Genome]

Phrase: "originally"

Phrase: "detected in an amyloid-enriched fraction,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0359583:enriched [Food]
   753   C0442726:Detected [Finding]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a fragment of its precursor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332255:fragment [Functional Concept]
   760   C1708096:Fragment [Qualitative Concept]

Phrase: "NACP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0285890:NACP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:NACP [Gene or Genome]
  1000   C2983377:NACP [Gene or Genome]

Phrase: "by cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "of the full-length cDNA (1"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0443225:Full [Qualitative Concept]
   812   C1444754:Length [Quantitative Concept]
   812   C1706316:LENGTH [Research Activity]
   741 E C0205166:Long [Qualitative Concept]
   741 E C1522425:Longest [Qualitative Concept]
   741 E C1706317:Long [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.7: Later, NACP turned out to be a human homologue of Torpedo synuclein (2). 

Phrase: "Later,"

Phrase: "NACP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0285890:NACP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:NACP [Gene or Genome]
  1000   C2983377:NACP [Gene or Genome]

Phrase: "turned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0541749:turned [Finding]
   966 E C1709743:Turn [Spatial Concept]

Phrase: "out to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "be"

Phrase: "a human homologue of Torpedo synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homologue [Gene or Genome]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.8: Therefore, it is also referred to as human -synuclein (3). 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "also"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.9: -Synuclein is abundant in presynaptic terminals of neurons (4). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "abundant in presynaptic terminals of neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346714:Abundant [Qualitative Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.10: Recently, two missense mutations in the -synuclein gene (5) were discovered in certain pedigrees with familial Parkinson's disease and were shown to segregate with the illness (6, 7). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "two missense mutations in the -synuclein gene"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0599155:Mutations, Missense [Genetic Function]
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "discovered in certain pedigrees"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030761:pedigrees [Intellectual Product]
   737   C1880355:Discover [Activity]

Phrase: "with familial Parkinson's disease"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0030567:Parkinson Disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "segregate with the illness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0221423:Illness [Finding]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.11: Shortly thereafter, -synuclein was identified as the major filamentous component of Lewy bodies (LBs) in Parkinson's disease (8, 9) and of cytoplasmic inclusions in multiple system atrophy (MSA) (10-12). 

Phrase: "Shortly thereafter, -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "identified as the major filamentous component of Lewy bodies (LBs)"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   764   C0085200:Lewy Bodies [Cell Component]
   742   C0205164:Major [Qualitative Concept]
   742   C0205396:Identified [Qualitative Concept]
   742   C0242821:bodies [Human]
   742   C0449432:Component [Manufactured Object]
   742   C1550043:Identified [Finding]
   742   C1551388:Identified [Functional Concept]
   742   C1705248:Component [Conceptual Entity]
   742   C1979891:Filamentous [Qualitative Concept]
   742   C1995017:Bodies [Cell Component]
   708 E C0460148:Body [Anatomical Structure]
   708 E C1268086:Body [Anatomical Structure]

Phrase: "in Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(8,"

Phrase: "9"

Phrase: ")"

Phrase: "and of cytoplasmic inclusions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0205708:Cytoplasmic Inclusions [Cell Component]
   770   C0010834:Cytoplasmic [Cell Component]
   770   C0521449:Cytoplasmic [Body Location or Region]
   770   C1515981:And [Idea or Concept]
   737   C1512693:Inclusion [Qualitative Concept]

Phrase: "in multiple system atrophy (MSA)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(10-12"

Phrase: ")."
Processing 00000000.tx.12: Thus, -synuclein appears to be a common pathogenic molecule in these diseases. 

Phrase: "Thus, -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a common pathogenic molecule in these diseases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0567416:Molecule [Substance]
   721   C0019247:Molecular Disease [Disease or Syndrome]
Processing 00000000.tx.13: Although the physiological role of -synuclein is unknown, -synuclein has the property of forming fibrils by itself in vitro, and mutations of -synuclein accelerate the fibril formation (13, 14). 

Phrase: "Although"

Phrase: "the physiological role of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "unknown, -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "the property of forming fibrils"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0871161:Property [Qualitative Concept]
   760   C1882134:Property [Conceptual Entity]
   760   C2347695:Property [Entity]

Phrase: "by itself in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "mutations of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.14: However, the vast majority of cases of neurodegenerative diseases associated with LBs or with -synuclein pathology, such as Parkinson's disease, dementia with Lewy bodies (DLB), MSA, and the LB variant of Alzheimer's disease, are sporadic, where wild-type -synuclein has shown to be abnormally accumulated as fibrillar structures. 

Phrase: "However,"

Phrase: "the vast majority of cases of neurodegenerative diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0680220:majority [Social Behavior]

Phrase: "associated with LBs"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0085200:Lewy Bodies [Cell Component]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1268086:Body [Anatomical Structure]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or with -synuclein pathology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]

Phrase: "such as Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "dementia with Lewy bodies (DLB),"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "MSA,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "the LB variant of Alzheimer's disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variant [Qualitative Concept]

Phrase: "are"

Phrase: "sporadic, where wild-type -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "abnormally"

Phrase: "accumulated as fibrillar structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:structures [Spatial Concept]
Processing 00000000.tx.15: It is therefore likely that at some stage(s) in the fibril formation of -synuclein, either the nucleation and/or the elongation steps should be somehow accelerated in diseased brains, or alternatively, some degradation process(es) of abnormal structures of -synuclein might be defective in those patients (15). 

Phrase: "It"

Phrase: "is"

Phrase: "therefore likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "that at some stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]

Phrase: "("

Phrase: "s) in the fibril formation of -synuclein,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0220781:formation [Biologic Function]
   748   C0225328:Fibril [Cell Component]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1948066:Fibril [Physical Object]
   748   C2603362:S' [Clinical Attribute]

Phrase: "either"

Phrase: "the nucleation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1979936:Nucleated [Qualitative Concept]

Phrase: "and/or"

Phrase: "the elongation steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "should"

Phrase: "be"

Phrase: "somehow"

Phrase: "accelerated in diseased brains,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0521110:Accelerated [Functional Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "alternatively,"

Phrase: "some degradation process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "(es) of abnormal structures of -synuclein"

Phrase: "might"

Phrase: "be"

Phrase: "defective in those patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332452:Defective [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.16: With respect to the amyloidogenesis of Alzheimer's disease, it was demonstrated in vitro that a seed of NAC can accelerate A fibril formation, and conversely, a seed of A can promote NAC fibril formation (16). 

Phrase: "With respect to the amyloidogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706803:Amyloidogenesis [Cell or Molecular Dysfunction]

Phrase: "of Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "it"

Phrase: "was"

Phrase: "demonstrated"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "that"

Phrase: "a seed of NAC"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0036563:Seed [Plant]
   770   C1705192:Seed [Laboratory Procedure]
   770   C1882540:{Seed} [Quantitative Concept]
   770   C2346495:Seed [Conceptual Entity]
   715 E C1519232:Seminal [Clinical Attribute]

Phrase: "can"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "A fibril formation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3544412:amyloid fibril formation [Molecular Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "conversely,"

Phrase: "a seed of A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0036563:Seed [Plant]
   770   C1705192:Seed [Laboratory Procedure]
   770   C1882540:{Seed} [Quantitative Concept]
   770   C2346495:Seed [Conceptual Entity]
   715 E C1519232:Seminal [Clinical Attribute]

Phrase: "can"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "NAC fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.17: Similarly, heterogeneous molecules could also be involved in the formation of -synuclein fibrils, leading to pathological structures of -synuclein such as LBs. 

Phrase: "Similarly,"

Phrase: "heterogeneous molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "involved in the formation of -synuclein fibrils,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0220781:formation [Biologic Function]
   748   C0225328:fibrils [Cell Component]
   748   C0439634:formation [Spatial Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1522492:Formation [Functional Concept]
   714 E C1948066:Fibril [Physical Object]

Phrase: "leading to pathological structures of -synuclein"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   753   C0030664:Pathological [Biomedical Occupation or Discipline]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332152:Leading [Temporal Concept]
   753   C0678594:structures [Spatial Concept]
   753   C1521733:Pathological [Functional Concept]
   753   C1522538:Leading [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "such as LBs."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.18: In this study, we performed a biochemical investigation of molecules that interact with -synuclein in the human brain, and we identified tubulin as one of the -synuclein binding/associated proteins. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a biochemical investigation of molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Investigation [Health Care Activity]
   760   C1552578:investigation [Idea or Concept]

Phrase: "that"

Phrase: "interact with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the human brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "tubulin as one of the -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C2937342:tubulin [Cell Component]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "/associated proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.19: This interaction was confirmed by co-immunoprecipitation experiments. 

Phrase: "This interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "confirmed by co-immunoprecipitation experiments."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   806   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0681814:Experiments [Research Activity]
   760   C0750484:Confirmed [Idea or Concept]
   726 E C1456348:Confirm [Qualitative Concept]
   726 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.20: Further, -synuclein was co-purified with microtubules. 

Phrase: "Further, -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "co-purified with microtubules."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026046:Microtubules [Cell Component]
   770   C1998793:Purified [Functional Concept]
Processing 00000000.tx.21: Double labeling immunofluorescence revealed that tubulin co-localized with -synuclein-positive pathological structures such as LBs, Lewy-related neurites in Parkinson's disease and DLB, and glial cytoplasmic inclusions (GCIs) in MSA. 

Phrase: "Double labeling immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0016318:Immunofluorescence [Laboratory Procedure]
   827   C0079603:Immunofluorescence [Laboratory Procedure]
   771 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   755 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "co-localized with -synuclein-positive pathological structures"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0030664:Pathological [Biomedical Occupation or Discipline]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392752:Localized [Spatial Concept]
   748   C0439178:% Positive [Quantitative Concept]
   748   C0678594:structures [Spatial Concept]
   748   C1446409:Positive [Qualitative Concept]
   748   C1514241:Positive [Finding]
   748   C1521733:Pathological [Functional Concept]
   748   C2825490:Positive [Qualitative Concept]

Phrase: "such as LBs,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "Lewy-related neurites in Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C3548404:Lewy neurite [Cell Component]
   753   C0085103:Neurites [Cell Component]

Phrase: "and"

Phrase: "DLB,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "glial cytoplasmic inclusions (GCIs) in MSA."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C3548440:glial cytoplasmic inclusion [Cell Component]
   778   C0205708:Cytoplasmic Inclusions [Cell Component]
   748   C0010834:Cytoplasmic [Cell Component]
   748   C0521449:Cytoplasmic [Body Location or Region]
   714   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.22: In vitro studies demonstrated that -synuclein fibril formation was initiated and accelerated in physiological media containing a small amount of tubulin. 

Phrase: "In vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "demonstrated"

Phrase: "that -synuclein fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "and"

Phrase: "accelerated in physiological media"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0205463:Physiological [Functional Concept]
   770   C0521110:Accelerated [Functional Concept]
   770   C1254021:Media [Tissue]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a small amount of tubulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.23: To our knowledge, this is the first demonstration of the initiation and promotion of -synuclein fibrillogenesis by an intrinsic neural protein under physiological conditions. 

Phrase: "To our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "this"

Phrase: "is"

Phrase: "the first demonstration of the initiation"

Phrase: "and"

Phrase: "promotion of -synuclein fibrillogenesis by an intrinsic neural protein"

Phrase: "under physiological conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.24: We speculate that the interaction between tubulin and -synuclein may be linked to -synuclein-associated neurodegenerative diseases.  

Phrase: "We"

Phrase: "speculate"

Phrase: "that"

Phrase: "the interaction between tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C3537022:Tubulin Interaction [Molecular Function]
   770   C1704675:Interaction [Functional Concept]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "to -synuclein-associated neurodegenerative diseases."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   836   C0243083:associated disease [Pathologic Function]
   804   C0012634:Diseases [Disease or Syndrome]
   733 E C1836721:MALS [Finding]
   733 E C3538764:MALS [Gene or Genome]
   733 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.25: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Expression and Purification of -Synuclein-- -Synuclein cDNA clone pHBS 6-1(1) was digested with NcoI and BglII, and the DNA fragment was ligated into an expression vector, pET-15b (Novagen), previously linearized with NcoI and BamHI. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Purification of -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "-- -"

Phrase: "Synuclein cDNA clone pHBS 6-1"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   799   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0009013:Clone [Cell]
   799   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1522642:Clone [Tissue]
   766   C0084178:PHB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   766   C1335208:PHB [Gene or Genome]
   727 E C1704387:Clonal [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "digested with NcoI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "BglII,"

Phrase: "and"

Phrase: "the DNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "ligated into an expression vector,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]

Phrase: "pET-15b"

Phrase: "(Novagen"

Phrase: ")"

Phrase: ","

Phrase: "previously"

Phrase: "linearized with NcoI"

Phrase: "and"

Phrase: "BamHI."
Processing 00000000.tx.26: The resultant pET--synuclein was used for transformation of Escherichia coli BL21(DE3) pLysS, and expression was induced by isopropyl-1-thio--D-galactopyranoside. 

Phrase: "The resultant pET--synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "used for transformation of Escherichia coli BL21"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0014834:Escherichia coli [Bacterium]
   757   C1524063:Use of [Functional Concept]
   748   C0014833:Escherichia [Bacterium]
   748   C0040682:Transformation [Cell Function]
   748   C0450615:BL21 [Body Location or Region]
   748   C1273517:used [Finding]
   748   C1510411:Transformation [Pathologic Function]
   748   C1705163:Transformation [Research Activity]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "(DE3"

Phrase: ")"

Phrase: "pLysS,"

Phrase: "and"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "induced by isopropyl-1-thio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205263:Induced [Functional Concept]
   760   C1412102:THIO [Gene or Genome]
   760   C2945717:isopropyl [Chemical Viewed Structurally]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "galactopyranoside."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016945:Galactopyranoside [Biologically Active Substance,Carbohydrate]
Processing 00000000.tx.27: The recombinant -synuclein was purified using two-dimensional HPLC methods as described previously (15). 

Phrase: "The recombinant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two-dimensional HPLC methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.28: The identity was confirmed and the purity was shown to be >98% by SDS-PAGE, immunoblotting, MALDI/TOF-mass spectrometry, and microsequencing analyses (15). 

Phrase: "The identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0424215:Identity [Mental Process]
  1000   C2003939:Identity [Finding]

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "the purity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1882508:Purity [Quantitative Concept]
   928 E C2247561:PurE [Molecular Function]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be >"

Phrase: "98% by SDS-PAGE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "immunoblotting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "MALDI/TOF-mass spectrometry,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1518101:MALDI-TOF Mass Spectrometry [Research Activity]
   861   C0037813:Mass Spectrometry [Laboratory Procedure]
   812   C0436196:Spectrometry [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "microsequencing analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.29: Preparation of Human Brain Extract-- A human brain neocortex (75g) was homogenized in 9volumes of 20mM phosphate buffer, pH 8.0,containing 150mM NaCl, 1mM EDTA, 1g ml1 pepstatin, and 10g ml1 leupeptin. 

Phrase: "Preparation of Human Brain Extract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "--"

Phrase: "A human brain neocortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0175173:Neocortex [Body Part, Organ, or Organ Component]

Phrase: "(75g"

Phrase: ")"

Phrase: "was"

Phrase: "homogenized in 9volumes of 20mM phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1g ml1 pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "10g ml1 leupeptin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.30: Insoluble materials were precipitated by centrifugation at 140,000g at 4C for 60min. 

Phrase: "Insoluble materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]

Phrase: "were"

Phrase: "precipitated by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "at 140,"

Phrase: "000g at 4C"

Phrase: "for 60min."
Processing 00000000.tx.31: Soluble proteins from three cycles of homogenization and centrifugation were pooled. 

Phrase: "Soluble proteins from three cycles of homogenization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "were"

Phrase: "pooled."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]
Processing 00000000.tx.32: Isolation and Characterization of -Synuclein-binding Proteins from a Human Brain Extract-- An affinity column was prepared by the conjugation of cyanogen bromide-activated Sepharose-4B resin (Pharmacia) and recombinant -synuclein (27mg) according to the manufacturer's instructions. 

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "Characterization of -Synuclein-binding Proteins from a Human Brain Extract"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C0033618:Protein Binding [Molecular Function]
   741   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]

Phrase: "-"

Phrase: "-"

Phrase: "An affinity column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "prepared by the conjugation of cyanogen bromide-activated Sepharose-4B resin"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   756   C0010511:Cyanogen Bromide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   756   C0036682:Sepharose 4B [Biomedical or Dental Material,Carbohydrate]
   738   C0006222:Bromide [Inorganic Chemical]
   738   C0035191:Resin [Biomedical or Dental Material]
   738   C0036681:Sepharose [Carbohydrate]
   738   C0056658:cyanogen [Hazardous or Poisonous Substance,Inorganic Chemical]
   738   C0450375:4b [Intellectual Product]
   738   C1160466:conjugation [Cell Function]
   738   C1879547:Activated [Activity]
   704 E C1515877:Activate [Functional Concept]
   704   C1521827:Prepare [Functional Concept]

Phrase: "(Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "and"

Phrase: "recombinant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(27mg"

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.33: Soluble proteins from the human brain were loaded onto the column, and the column was then washed with a large volume of loading buffer, 50mM PBS, pH 7.0,at 4C. 

Phrase: "Soluble proteins from the human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "loaded onto the column,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1706132:Column [Idea or Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "the column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed with a large volume of loading buffer,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0449468:*Volume [Quantitative Concept]
   744   C0549177:Large [Quantitative Concept]
   744   C1548982:Washed [Idea or Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C1708715:Loading [Activity]
   744   C2700258:Volume [Laboratory Procedure]
   711 E C0441648:Wash [Activity]
   711 E C1550025:Load [Idea or Concept]
   711 E C1704782:Load [Manufactured Object]

Phrase: "50mM PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720830:PBS [Disease or Syndrome]
   861   C1823521:PBS [Gene or Genome]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.34: The adsorbed proteins were eluted with 50mM sodium citrate, pH 3.0,containing 0.5M NaCl. 

Phrase: "The adsorbed proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with 50mM sodium citrate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0142825:sodium citrate [Organic Chemical,Pharmacologic Substance]
   760   C0008857:Citrate [Organic Chemical]
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   760   C0450400:50mm [Quantitative Concept]
   760   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 3.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5M NaCl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.35: An identical control experiment was performed using a glycine-Sepharose-4B column. 

Phrase: "An identical control experiment"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0243148:control [Qualitative Concept]
   827   C0681814:Experiment [Research Activity]
   827   C1550141:Control [Substance]
   827   C1706386:Experiment [Conceptual Entity]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   755 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a glycine-Sepharose-4B column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]
Processing 00000000.tx.36: -Synuclein-binding proteins were purified from the adsorbed fraction obtained from the -synuclein affinity column by standard gel-cut methods followed by a reversed phase HPLC and characterized by immunoblotting, mass spectrometry, and microsequencing analyses. 

Phrase: "-Synuclein-binding proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "were"

Phrase: "purified from the adsorbed fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1998793:Purified [Functional Concept]

Phrase: "obtained from the -synuclein affinity column"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1301820:Obtained [Functional Concept]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C1706132:Column [Idea or Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "by standard gel-cut methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: "followed by a reversed phase HPLC"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   719   C1555029:Reverse [Idea or Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "characterized by immunoblotting,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C1880022:Characterized [Activity]

Phrase: "mass spectrometry,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "microsequencing analyses."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.37: Isolation of Microtubules and Tubulin from Rat Brain-- Microtubules were isolated from rat brains by two cycles of a temperature-dependent assembly and disassembly method (17) in PIPES buffer (0.1M PIPES, pH 6.8,1mM EGTA, 1mM MgCl2) containing 1mM GTP, 1g ml1 pepstatin, and 10g ml1 leupeptin, and tubulin was purified from the microtubule fraction by phosphocellulose (Whatman P11) column chromatography (18). 

Phrase: "Isolation of Microtubules"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0204727:Isolation [Therapeutic or Preventive Procedure]
   790   C0205409:Isolation [Functional Concept]
   790   C0220862:isolation [Laboratory Procedure]
   718 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "Tubulin from Rat Brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2937342:tubulin [Cell Component]

Phrase: "--"

Phrase: "Microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "were"

Phrase: "isolated from rat brains"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   816   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "by two cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "of a temperature-dependent assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "disassembly method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(17"

Phrase: ")"

Phrase: "in PIPES buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(0.1M PIPES,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0071109:PIPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   793 E C1709545:PIPE [Pharmacologic Substance]
   793 E C2828033:Pipe [Manufactured Object]

Phrase: "pH 6.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1mM MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "containing 1mM GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "1g ml1 pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "10g ml1 leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "was"

Phrase: "purified from the microtubule fraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0026046:Micro-tubule [Cell Component]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1998793:Purified [Functional Concept]

Phrase: "by phosphocellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070824:phosphocellulose [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Whatman P11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0966870:p11 [Amino Acid, Peptide, or Protein,Receptor]
   861   C3538774:P11 [Gene or Genome]

Phrase: ")"

Phrase: "column chromatography"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0684296:Column Chromatography [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
   761 E C0302647:chromatograph [Medical Device]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.38: The purity of the tubulin was determined to be >98% by SDS-PAGE and immunoblot analyses. 

Phrase: "The purity of the tubulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882508:Purity [Quantitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be >"

Phrase: "98% by SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblot analyses."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.39: Reassembly of microtubules was performed at 37C for 20min followed by 10min of incubation with 10M taxol for microtubule stabilization. 

Phrase: "Reassembly of microtubules"

Phrase: "was"

Phrase: "performed at 37C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for 20min"

Phrase: "followed by 10min of incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0332283:Followed by [Temporal Concept]
           followed
   726 E C1719822:Follow [Intellectual Product]

Phrase: "with 10M taxol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678133:Taxol [Organic Chemical,Pharmacologic Substance]

Phrase: "for microtubule stabilization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513285:Microtubule Stabilization [Cell Function]
   861   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.40: Immunoprecipitation and Immunoblotting-- Primary antibodies against the N-terminal region of -synuclein (MDV2), the NAC domain (EQV1), and the C-terminal region of -synuclein (PQE3), and -synuclein-specific antibody (REE1) were described previously (9, 10). 

Phrase: "Immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "Immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "--"

Phrase: "Primary antibodies against the N-terminal region of -synuclein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   708 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(MDV2"

Phrase: ")"

Phrase: ","

Phrase: "the NAC domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "(EQV1"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the C-terminal region of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(PQE3"

Phrase: ")"

Phrase: ","

Phrase: "and -"

Phrase: "synuclein-specific antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(REE1"

Phrase: ")"

Phrase: "were"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.41: Stringent immunoprecipitation was performed using a fraction of rat brain in radioimmune precipitation buffer (50mM PBS, pH 7.4,1mM EGTA, 1% Nonidet P-40, and 0.5% sodium deoxycholate). 

Phrase: "Stringent immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fraction of rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "in radioimmune precipitation buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(50mM PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720830:PBS [Disease or Syndrome]
   861   C1823521:PBS [Gene or Genome]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "0.5% sodium deoxycholate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.42: Antibodies PQE3, EQV1, and anti--tubulin (mouse monoclonal clone DM 1A, Sigma) were added and incubated at 4C for 2h. 

Phrase: "Antibodies PQE3,"

Phrase: "EQV1,"

Phrase: "and"

Phrase: "anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "(mouse monoclonal clone DM 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450344:1A [Intellectual Product]
   804   C1553633:1a [Medical Device]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]
Processing 00000000.tx.43: Antigen-antibody complexes were collected with protein A-Sepharose (Sigma). 

Phrase: "Antigen-antibody complexes"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0003313:Antigen-Antibody Complexes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   966 E C2939434:Antigen-antibody complex [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0368675:antigen antibody [Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0003320:Antigen [Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]
   727 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "were"

Phrase: "collected with protein A-Sepharose"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.44: The beads were washed five times by centrifugation with 1% Triton X-100 in PBS and then boiled for 5min in SDS-sample buffer. 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "five times by centrifugation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "with 1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "boiled for 5min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]

Phrase: "in SDS-sample buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.45: Following SDS-PAGE and immunoblotting, the signals were detected with chemiluminescence reagents (PerkinElmer Life Sciences) and Hyper-ECL film (Amersham Biosciences) as described (9, 10). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "the signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "detected with chemiluminescence reagents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0442726:Detected [Finding]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "Hyper-ECL film"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086296:Film [Manufactured Object]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.46: Anti--tubulin (clone TUB 2.1,Sigma), TAU-2 (NeoMarkers), and anti-MAP5 (identical to MAP1b) (Chemicon International) antibodies were also employed. 

Phrase: "Anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "(clone TUB 2.1,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0009013:Clone [Cell]
   812   C1421225:TUB [Gene or Genome]
   812   C1522642:Clone [Tissue]
   812   C1553464:Tub [Manufactured Object]
   812   C2700086:Tub [Quantitative Concept]
   741 E C1704387:Clonal [Qualitative Concept]
   712 E C0796368:clonality [Diagnostic Procedure]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "TAU-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(NeoMarkers"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anti-MAP5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0250759:MAP5 [Amino Acid, Peptide, or Protein]
   861   C1417004:MAP5 [Gene or Genome]

Phrase: "(identical to MAP1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: ")"

Phrase: "(Chemicon"

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "employed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]
Processing 00000000.tx.47: It was confirmed that EQV1 and PQE3 did not cross react with tubulin, whereas tubulin antibodies were unable to react with -synuclein. 

Phrase: "It"

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that EQV1"

Phrase: "and"

Phrase: "PQE3"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cross react with tubulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2828360:Cross [Conceptual Entity]
   770   C2937342:tubulin [Cell Component]

Phrase: "whereas"

Phrase: "tubulin antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "react with -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.48: In Vitro Fibrillization-- -Synuclein (100-700 M) in 25l of PBS, pH7.4, was incubated with a fixed amount of tubulin (1M) at 37C without agitation for 0-15 days with or without 1M each MgCl2 and GTP. 

Phrase: "In Vitro Fibrillization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "-- -"

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100-700"

Phrase: "M) in 25l of PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]

Phrase: "pH7.4,"

Phrase: "was"

Phrase: "incubated with a fixed amount of tubulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0231441:Fixed [Finding]
   748   C0443218:Fixed [Qualitative Concept]
   748   C1265611:Amount [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C2827483:Fixed [Body Substance]
   748   C2937342:tubulin [Cell Component]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "at 37C"

Phrase: "without agitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085631:Agitation [Sign or Symptom]

Phrase: "for 0-15 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "with"

Phrase: "or without 1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470296:1M [Quantitative Concept]

Phrase: "each MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "GTP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.49: Control experiments were performed using either incubation with BSA or incubation in the absence of tubulin or -synuclein. 

Phrase: "Control experiments"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009932:control experiments [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0681814:Experiments [Research Activity]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either incubation with BSA"

Phrase: "or"

Phrase: "incubation in the absence of tubulin or -synuclein."
Processing 00000000.tx.50: The resulting fibrils were monitored by light scattering at OD 400nm (19, 20) using 1l of the reaction mixture with a Gene Spec III spectrophotometer (Hitachi) and examined by immunoelectron microscopy (immuno-EM). 

Phrase: "The resulting fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "monitored by light scattering"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0596837:Light Scattering [Phenomenon or Process]
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C0439742:Scattering [Spatial Concept]
   770   C1306462:Light [Functional Concept]
   770   C1881376:Light [Qualitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "at OD 400nm"

Phrase: "(19,"

Phrase: "20"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1l of the reaction mixture"

Phrase: "with a Gene Spec III spectrophotometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0183400:Spectrophotometer [Medical Device]

Phrase: "(Hitachi"

Phrase: ")"

Phrase: "and"

Phrase: "examined by immunoelectron microscopy (immuno-EM)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0079835:Microscopy, Immuno-Electron [Diagnostic Procedure]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0332128:Examined [Finding]
Processing 00000000.tx.51: Immunoelectron Microscopy-- For immunonegative staining, aliquots of microtubules purified from rat brains or of -synuclein fibrils in the presence of tubulin were placed on Formvar-coated nickel grids and incubated with one of the following primary antibodies: anti--tubulin (1:40), anti--tubulin (1:40), TAU-2 (1:25), MDV2 (1:40), EQV1 (1:40), PQE3 (1:40), REE1 (1:40), or anti-A (1:50, DAKO). 

Phrase: "Immunoelectron Microscopy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0079835:Microscopy, Immuno-Electron [Diagnostic Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "For immunonegative staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "aliquots of microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1510844:Aliquot [Quantitative Concept]

Phrase: "purified from rat brains"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   816   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C1998793:Purified [Functional Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "of -synuclein fibrils in the presence of tubulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0225328:fibrils [Cell Component]
   711 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "placed on Formvar-coated nickel grids"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   753   C0028013:nickel [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0950318:Formvar [Hazardous or Poisonous Substance,Organic Chemical]
   753   C1522408:Coated [Qualitative Concept]
   753   C2348274:Nickel [Element, Ion, or Isotope]
   719   C0442504:Place [Spatial Concept]
   719 E C0453946:Coat [Manufactured Object]
   719   C1415284:GRID [Gene or Genome]
   719   C1704765:Place [Functional Concept]
   719   C1882509:Place [Activity]
   719   C2348395:Grid [Medical Device]
   719   C2825313:Grid [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]
   719   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "incubated with one of the following primary antibodies"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0205225:Primary [Qualitative Concept]
   744   C0205447:One [Quantitative Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]
   744   C1439852:Incubated [Laboratory Procedure]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   711   C0332283:follow [Temporal Concept]
   711   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "TAU-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "25"

Phrase: ")"

Phrase: ","

Phrase: "MDV2"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "EQV1"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "PQE3"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "REE1"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50,"

Phrase: "DAKO"

Phrase: ")."
Processing 00000000.tx.52: The immunoreaction was visualized by using 10-nm diameter gold particles (1:20, British BioCell) as described previously (21). 

Phrase: "The immunoreaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872193:immunoreaction [Organism Function]

Phrase: "was"

Phrase: "visualized by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "10-nm diameter gold particles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0597177:particles [Chemical Viewed Structurally]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "20,"

Phrase: "British BioCell"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.53: For postembedding EM, formalin-fixed tissue from the dorsal motor nucleus of the vagus nerve of a patient with DLB was embedded in LR White resin (London Resin). 

Phrase: "For postembedding EM,"

Phrase: "formalin-fixed tissue from the dorsal motor nucleus of the vagus nerve"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C0027757:Nerve Tissue [Tissue]
   751   C1762608:Nerve tissue [Tissue]
   736   C0040300:Tissue [Tissue]
   736   C1547928:Tissue [Intellectual Product]

Phrase: "of a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with DLB"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   888   C0752347:dementia lewy bodies [Disease or Syndrome]
   840   C0085200:Lewy Bodies [Cell Component]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0242821:bodies [Human]
   804   C0332287:With [Qualitative Concept]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   804   C1705690:With [Intellectual Product]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "was"

Phrase: "embedded in LR White resin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0065208:LR-white resin [Biomedical or Dental Material,Chemical Viewed Structurally]
           LR white
   760   C0007457:White [Population Group]
   760   C0023617:LR [Geographic Area]
   760   C0035191:Resin [Biomedical or Dental Material]
   760   C0043157:White [Population Group]
   760   C0220938:White [Qualitative Concept]
   760   C1707903:Embedded [Laboratory Procedure]
   760   C2986899:LR [Idea or Concept]

Phrase: "(London Resin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035191:Resin [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.54: Ultrathin sections were placed on nickel grids and then incubated with PQE3 and finally with 5-nm diameter immunogold particles (21). 

Phrase: "Ultrathin sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "placed on nickel grids"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0028013:nickel [Biologically Active Substance,Element, Ion, or Isotope]
   770   C2348274:Nickel [Element, Ion, or Isotope]
   737   C0442504:Place [Spatial Concept]
   737   C1415284:GRID [Gene or Genome]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C2348395:Grid [Medical Device]
   737   C2825313:Grid [Manufactured Object]
   737   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with PQE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "finally with 5-nm diameter immunogold particles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0312860:NM [Cell Function]
   748   C0597177:particles [Chemical Viewed Structurally]
   748   C1301886:Diameter [Quantitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.55: Immunofluorescence Microscopy-- The co-localization of PQE3- and tubulin-epitopes was studied using formalin-fixed paraffin-embedded sections of the dorsal vagus nucleus of a patient with Parkinson's disease, of cervical sympathetic ganglia of that with DLB, and of the pontine basis of that with MSA. 

Phrase: "Immunofluorescence Microscopy"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The co-localization of PQE3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "tubulin-epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "was"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "formalin-fixed paraffin-embedded sections of the dorsal vagus nucleus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   706   C0205155:Section [Spatial Concept]
   706   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   706   C1522472:Section [Substance]
   706   C1552923:Section [Quantitative Concept]
   706   C1705191:Section [Physical Object]

Phrase: "of a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "of cervical sympathetic ganglia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   983   C0446846:Cervical sympathetic ganglion [Body Part, Organ, or Organ Component]
           Cervical ganglia
   901   C0017071:Sympathetic Ganglia [Body Part, Organ, or Organ Component]
   827   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   793 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "of that"

Phrase: "with DLB,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   888   C0752347:dementia lewy bodies [Disease or Syndrome]
   840   C0085200:Lewy Bodies [Cell Component]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0242821:bodies [Human]
   804   C0332287:With [Qualitative Concept]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   804   C1705690:With [Intellectual Product]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and of the pontine basis of that"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0032639:Pontine [Body Part, Organ, or Organ Component]
   748   C1515981:And [Idea or Concept]
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]

Phrase: "with MSA."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.56: Sections were incubated in a solution of PQE3 (1:400) and either anti--tubulin (1:200) or anti--tubulin (1:200) and then incubated with FITC-conjugated anti-mouse IgG (1:30, BIOSOURCE Int., Camarillo, CA) and tetraethyl sulforhodamine (Rhodamine) conjugated with anti-rabbit IgG (1:80, BIOSOURCE).  

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated in a solution of PQE3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "400"

Phrase: ")"

Phrase: "and"

Phrase: "either anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "or"

Phrase: "anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with FITC-conjugated anti-mouse IgG (1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0522529:Conjugated [Spatial Concept]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: ":"

Phrase: "30,"

Phrase: "BIOSOURCE Int.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]

Phrase: "Camarillo,"

Phrase: "CA)"

Phrase: "and"

Phrase: "tetraethyl sulforhodamine"

Phrase: "(Rhodamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "conjugated with anti-rabbit IgG"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0034493:Rabbit [Mammal]
   760   C0522529:Conjugated [Spatial Concept]
   726 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "80,"

Phrase: "BIOSOURCE"

Phrase: ")."
Processing 00000000.tx.57: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Tubulin Is a Binding/Associated Protein of -Synuclein-- To detect molecules that interact with -synuclein in the human brain, we subjected human brain proteins to -synuclein affinity column chromatography. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "Is"

Phrase: "a Binding/Associated Protein of -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "interact with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the human brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "we"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "human brain proteins to -synuclein affinity column chromatography."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   822   C0008551:Chromatography, Affinity [Laboratory Procedure]
   812   C0684296:Column Chromatography [Laboratory Procedure]
   793   C0008550:Chromatography [Laboratory Procedure]
   793   C1185738:Column [Body Part, Organ, or Organ Component]
   793   C1706132:Column [Idea or Concept]
Processing 00000000.tx.58: Employing a recombinant -synuclein column, several proteins were isolated as possible -synuclein-binding/associated proteins (Fig. 1a). 

Phrase: "Employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a recombinant -synuclein column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "several proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "isolated as possible -synuclein-"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205409:Isolated [Functional Concept]
   770   C0332149:Possible [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1705910:Possible [Qualitative Concept]
   770   C2362652:Possible [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "/associated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.59: After purification of the proteins bound to the -synuclein column by a reversed phase HPLC, several proteins were determined from their amino acid sequences. 

Phrase: "After purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "of the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bound to the -synuclein column"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1689898:% bound [Quantitative Concept]
   760   C1706132:Column [Idea or Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "by a reversed phase HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: "several proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "determined from their amino acid sequences."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0002518:Sequences, Amino Acid [Amino Acid Sequence]
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0162326:Sequences [Nucleotide Sequence]
   753   C0202406:Acid [Laboratory Procedure]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.60: One of them with an apparent molecular weight of ~50 kDa (Fig. 1a, arrowhead) was sequenced as MRECISIHVG for the N terminus, and VGINYQPPTVVPGGDLAK for a peptide from the Achromobacter lyticus protease digest. 

Phrase: "One of them"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "with an apparent molecular weight of ~50 kDa (Fig. 1a,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0450344:1A [Intellectual Product]
   793   C1553633:1a [Medical Device]

Phrase: "arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: "was"

Phrase: "sequenced as MRECISIHVG"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0004793:Sequence [Nucleotide Sequence]
   756   C0162326:Sequence [Nucleotide Sequence]
   756   C0162327:Sequence [Nucleotide Sequence]
   756   C1519249:Sequence [Functional Concept]

Phrase: "for the N terminus,"

Phrase: "and"

Phrase: "VGINYQPPTVVPGGDLAK for a peptide"

Phrase: "from the Achromobacter lyticus protease digest."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0868946:digest [Physiologic Function]
Processing 00000000.tx.61: In a data base search (SWISS-PROT), both sequences were found to belong to human -tubulin. 

Phrase: "In a data base search"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]
   734   C0242356:Database [Intellectual Product]
   734   C0993637:Data Base [Intellectual Product]

Phrase: "(SWISS-PROT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0950143:SWISS-PROT [Intellectual Product]
  1000   C1710264:Swiss_Prot [Conceptual Entity]
   861   C0241315:Swiss [Population Group]
   861   C0555903:PROT [Laboratory Procedure]
   861   C1420218:PROT [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "both sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "belong to human -tubulin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0086418:Human [Human]
   770   C2937342:tubulin [Cell Component]
Processing 00000000.tx.62: To confirm the interaction between -synuclein and -tubulin, immunoprecipitation was carried out, and -tubulin was co-precipitated with endogenous -synuclein in the cytoplasmic fraction of the rat brain (Fig. 1b) and vice versa (Fig. 1c). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the interaction between -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and -"

Phrase: "tubulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "and -"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "was"

Phrase: "co-precipitated with endogenous -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205227:Endogenous [Functional Concept]
   726   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "in the cytoplasmic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "of the rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "vice versa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]

Phrase: "(Fig. 1c"

Phrase: ")."
Processing 00000000.tx.63: -Tubulin was also co-precipitated using anti--synuclein antibodies (not shown), indicating the interaction of -synuclein with - tubulin heterodimers. 

Phrase: "-Tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "was"

Phrase: "also"

Phrase: "co-precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti"

Phrase: "--"

Phrase: "synuclein antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "the interaction of -synuclein with - tubulin heterodimers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.64: View larger version (38K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.65: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.66: Interaction of -synuclein and -tubulin. a, soluble proteins of human brain were applied to an -synuclein-conjugated Sepharose-4B column, and bound proteins were analyzed by SDS-PAGE and detected by silver staining. 

Phrase: "Interaction of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "tubulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "a,"

Phrase: "soluble proteins of human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "applied to an -synuclein-conjugated Sepharose-4B column,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0036682:Sepharose 4B [Biomedical or Dental Material,Carbohydrate]
   744   C0036681:Sepharose [Carbohydrate]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0185125:Applied [Health Care Activity]
   744   C0450375:4b [Intellectual Product]
   744   C0522529:Conjugated [Spatial Concept]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1706132:Column [Idea or Concept]
   711 E C1632850:Apply [Functional Concept]
   711 E C1879355:Apply [Functional Concept]

Phrase: "and"

Phrase: "bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "detected by silver staining."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1293950:Silver Staining [Laboratory Procedure]
   770   C0037125:Silver [Element, Ion, or Isotope]
   770   C0442726:Detected [Finding]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   770   C1305285:Silver [Qualitative Concept]
   770   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1704680:Staining [Finding]
Processing 00000000.tx.67: Proteins adsorbed to the affinity column (AC) were applied in lane 2and to the control column (CC) in lane 3, and the recombinant -synuclein used in this study was applied in lane 4. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "adsorbed to the affinity column (AC)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1706132:Column [Idea or Concept]

Phrase: "were"

Phrase: "applied in lane 2and"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0185125:Applied [Health Care Activity]
   770   C1708639:Lane [Spatial Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "to the control column (CC)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0243148:control [Qualitative Concept]
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1550141:Control [Substance]
   861   C1706132:Column [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "in lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "the recombinant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "applied in lane 4."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0185125:Applied [Health Care Activity]
   770   C1708639:Lane [Spatial Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.68: After purification of the upper band (arrowhead), amino acid sequencing revealed the protein to be -tubulin (see text). 

Phrase: "After purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "of the upper band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "(arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: ","

Phrase: "amino acid sequencing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0751971:Amino Acid Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the protein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "be -"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.69: b, -tubulin was co-immunoprecipitated (IP) from the cytosolic fraction of rat brain with anti--synuclein antibodies PQE3 and EQV1. 

Phrase: "b, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "was"

Phrase: "co-immunoprecipitated (IP) from the cytosolic fraction of rat brain"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C1264633:Fraction of [Quantitative Concept]
           Fraction
   764   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1383501:Cytosolic [Cell Component]
   742   C1554103:Fraction [Idea or Concept]
   708   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "with anti"

Phrase: "--"

Phrase: "synuclein antibodies PQE3"

Phrase: "and"

Phrase: "EQV1."
Processing 00000000.tx.70: The immunoprecipitated proteins were separated by 12% SDS-PAGE, analyzed by immunoblot (IB), and detected with anti--tubulin antibody (1:5,000). 

Phrase: "The immunoprecipitated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by 12% SDS-PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1704732:Page [Intellectual Product]

Phrase: "analyzed by immunoblot (IB),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblot [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "detected with anti--tubulin antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C2937342:tubulin [Cell Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.71: c, -synuclein was co-immunoprecipitated with anti--tubulin antibody and detected with -synuclein-specific antibodies PQE3 (1:10,000) and EQV1 (1:10,000). 

Phrase: "c, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "co-immunoprecipitated with anti--tubulin antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C2937342:tubulin [Cell Component]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "detected with -synuclein-specific antibodies PQE3"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   773   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205369:Specific [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1552740:specific [Intellectual Product]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: ")"

Phrase: "and"

Phrase: "EQV1"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: ")."
Processing 00000000.tx.72: - and -Synucleins Are Associated with Microtubules-- To prove the binding or association of -synuclein to microtubules, we purified microtubules from rat brains by two cycles of polymerization and depolymerization (17, 18). 

Phrase: "-"

Phrase: "and -"

Phrase: "Synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Are"

Phrase: "Associated with Microtubules"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026046:Microtubules [Cell Component]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prove"

Phrase: "the binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "or"

Phrase: "association of -synuclein to microtubules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "microtubules from rat brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026046:Microtubules [Cell Component]

Phrase: "by two cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "of polymerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "and"

Phrase: "depolymerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301644:Depolymerisation [Phenomenon or Process]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.73: First, the presence of -tubulin, -tubulin, tau, and MAP5 (MAP1b) was confirmed in the purified microtubules by immunoblot analyses (Fig. 2a). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the presence of -tubulin, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2937342:tubulin [Cell Component]

Phrase: "tubulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "MAP5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0250759:MAP5 [Amino Acid, Peptide, or Protein]
  1000   C1417004:MAP5 [Gene or Genome]

Phrase: "(MAP1b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0250759:MAP1B [Amino Acid, Peptide, or Protein]
  1000   C1417004:MAP1B [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "confirmed in the purified microtubules"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0026046:Microtubules [Cell Component]
   760   C0521093:confirmed [Qualitative Concept]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1998793:Purified [Functional Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "by immunoblot analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 2a"

Phrase: ")."
Processing 00000000.tx.74: -Synuclein was also detected in the same sample with three kinds of anti--synuclein antibodies (MDV2, EQV1, and PQE3) that interact with epitopes covering the entire -synuclein molecule (Fig. 2, b and c). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also"

Phrase: "detected in the same sample"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0370003:Sample [Substance]
   760   C0442726:Detected [Finding]
   760   C0445247:Same [Qualitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "with three kinds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332307:Kind [Qualitative Concept]

Phrase: "of anti"

Phrase: "--"

Phrase: "synuclein antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(MDV2,"

Phrase: "EQV1,"

Phrase: "and"

Phrase: "PQE3"

Phrase: ")"

Phrase: "that"

Phrase: "interact with epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003316:Epitopes [Immunologic Factor]

Phrase: "covering"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0180153:covering [Medical Device]
  1000   C0439844:covering [Functional Concept]
   966 E C1707529:Cover [Medical Device]
   966 E C1999244:Cover [Functional Concept]

Phrase: "the entire -synuclein molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "c)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.75: Doublet-like bands with molecular mass of about 19kDa were detected with MDV2 (anti-- and -synuclein), and a band corresponding to the upper one was detected with REE1 (anti--synuclein) antibodies (Fig. 2c), indicating that both - and -synucleins are present in the purified microtubule fraction. 

Phrase: "Doublet-"

Phrase: "like bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "with molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]

Phrase: "of about 19kDa"

Phrase: "were"

Phrase: "detected with MDV2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(anti"

Phrase: "-"

Phrase: "-"

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0230715:A band [Cell Component]
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "corresponding to the upper one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205447:One [Quantitative Concept]
   760   C1282910:Upper [Spatial Concept]

Phrase: "was"

Phrase: "detected with REE1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(anti"

Phrase: "--"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 2c"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "both -"

Phrase: "and -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "present in the purified microtubule fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
Processing 00000000.tx.76: These two bands disappeared when these antibodies were preadsorbed with each of the respective peptide antigens, showing the specificity (Fig. 2c). 

Phrase: "These two bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "disappeared"

Phrase: "when"

Phrase: "these antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "preadsorbed with each of the respective peptide antigens,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0003320:Antigens [Immunologic Factor]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "(Fig. 2c"

Phrase: ")."
Processing 00000000.tx.77: View larger version (45K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(45K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.78: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.79: -Synuclein is associated with microtubules. a, microtubules were purified from rat brain by two cycles of polymerization and depolymerization, and -synuclein was co-purified with microtubules. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "associated with microtubules."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026046:Microtubules [Cell Component]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "a,"

Phrase: "microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "were"

Phrase: "purified from rat brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1998793:Purified [Functional Concept]

Phrase: "by two cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "of polymerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "and"

Phrase: "depolymerization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301644:Depolymerisation [Phenomenon or Process]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "co-purified with microtubules."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026046:Microtubules [Cell Component]
   770   C1998793:Purified [Functional Concept]
Processing 00000000.tx.80: Following SDS-PAGE (12%), immunoblots were incubated with anti--tubulin (1:5,000), anti--tubulin (1:5,000), TAU-2 (1:500), or anti-MAP5 (MAP1b) (1:500) antibodies. b, purified samples of different concentrations (15,30,and 60g of protein) were analyzed by 12% SDS-PAGE followed by immunoblotting and were detected with PQE3 (1:10,000) or EQV1 (1:10,000). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "SDS-PAGE (12%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   827   C1704732:Page [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated with anti--tubulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C2937342:tubulin [Cell Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "TAU-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti-MAP5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0250759:MAP5 [Amino Acid, Peptide, or Protein]
   861   C1417004:MAP5 [Gene or Genome]

Phrase: "(MAP1b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0250759:MAP1B [Amino Acid, Peptide, or Protein]
  1000   C1417004:MAP1B [Gene or Genome]

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: "antibodies. b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0368674:antibodies b [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "purified samples of different concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "(15,"

Phrase: "30,"

Phrase: "and"

Phrase: "60g of protein"

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by 12% SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0936012:Analyzed [Research Activity]
   760   C1704732:Page [Intellectual Product]

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "were"

Phrase: "detected with PQE3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: ")"

Phrase: "or"

Phrase: "EQV1"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: ")."
Processing 00000000.tx.81: A dose-dependent specific immunoreaction with a band of molecular mass of about 19kDa demonstrated the presence of -synuclein in association with purified microtubules. c, control experiments were carried out using different -synuclein-specific antibodies (PQE3 and EQV1) and peptide-preadsorbed (pa) antibodies. 

Phrase: "A dose-dependent specific immunoreaction with a band of molecular mass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0872193:immunoreaction [Organism Function]

Phrase: "of about 19kDa"

Phrase: "demonstrated"

Phrase: "the presence of -synuclein in association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with purified microtubules. c,"

Phrase: "control experiments"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009932:control experiments [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0681814:Experiments [Research Activity]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different -synuclein-specific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(PQE3"

Phrase: "and"

Phrase: "EQV1"

Phrase: ")"

Phrase: "and"

Phrase: "peptide-preadsorbed (pa) antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.82: Purified samples (40g/lane) were separated by 18% SDS-PAGE (Tris-Tricine) and immunoblotted with various antibodies, including REE1, specific for -synuclein, showing that -synuclein was also associated with purified microtubules. 

Phrase: "Purified samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(40g/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "separated by 18% SDS-PAGE (Tris-Tricine"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077068:tricine [Organic Chemical]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C0814229:TRI [Intellectual Product]
   748   C1704732:Page [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "immunoblotted with various antibodies,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   737   C0020985:Immunoblot [Laboratory Procedure]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "REE1,"

Phrase: "specific for -synuclein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also"

Phrase: "associated with purified microtubules."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0026046:Microtubules [Cell Component]
   770   C1998793:Purified [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.83: MDV2 detects both - and -synuclein (see text). 

Phrase: "MDV2"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "both -"

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.84: The association of -synuclein with microtubules was then examined by EM. 

Phrase: "The association of -synuclein with microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined by EM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332128:Examined [Finding]
Processing 00000000.tx.85: Microtubules with a diameter of 24-26 nm were decorated by gold particles in immuno-EM using either anti--tubulin (Fig. 3a), or anti--tubulin (not shown) antibody. 

Phrase: "Microtubules with a diameter of 24-26 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0026046:Microtubules [Cell Component]

Phrase: "were"

Phrase: "decorated by gold particles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0597177:particles [Chemical Viewed Structurally]
   770   C1304897:Gold [Functional Concept]

Phrase: "in immuno-EM"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0079835:Microscopy, Immuno-Electron [Diagnostic Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2937342:tubulin [Cell Component]

Phrase: "(Fig. 3a"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.86: Tau is a well-characterized microtubule-associated protein (MAP). 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "a well-characterized microtubule-associated protein (MAP)."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   884   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026046:Micro-tubule [Cell Component]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332281:Associated [Qualitative Concept]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.87: Therefore, TAU-2 was used as a positive control to show its interaction with purified microtubules (Fig. 3b). 

Phrase: "Therefore,"

Phrase: "TAU-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "used as a positive control to"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C1883676:Positive Control [Conceptual Entity]
   753   C0243148:control [Qualitative Concept]
   753   C0439178:% Positive [Quantitative Concept]
   753   C1273517:used [Finding]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C2825490:Positive [Qualitative Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "its interaction with purified microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "(Fig. 3b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.88: In contrast to this, anti-A was used as a negative control for this experiment (Fig. 3f). 

Phrase: "In contrast to this,"

Phrase: "anti-A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "used as a negative control"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1639518:% negative control [Quantitative Concept]
   806   C1947986:Negative Control [Conceptual Entity]
   760   C0205160:Negative [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1513916:Negative [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "for this experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "(Fig. 3f"

Phrase: ")."
Processing 00000000.tx.89: All of the anti--synuclein antibodies (MDV2 (Fig. 3c), EQV1 (not shown), PQE3 (Fig. 3d), and anti--synuclein antibody, REE1 (Fig. 3e)) showed positive immunoreactions with purified microtubules. 

Phrase: "All of the anti"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]

Phrase: "--"

Phrase: "synuclein antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(MDV2"

Phrase: "(Fig. 3c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "EQV1"

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "PQE3"

Phrase: "(Fig. 3d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anti"

Phrase: "--"

Phrase: "synuclein antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "REE1"

Phrase: "(Fig. 3e"

Phrase: ")"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "positive immunoreactions with purified microtubules."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0872193:immunoreaction [Organism Function]
Processing 00000000.tx.90: These tubules were not labeled when the primary antibodies for - and -synucleins were preadsorbed with the respective antigen (not shown). 

Phrase: "These tubules"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "when"

Phrase: "the primary antibodies for -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "preadsorbed with the respective antigen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003320:Antigen [Immunologic Factor]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: These results suggest that both - and -synucleins are associated with purified microtubules. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both -"

Phrase: "and -"

Phrase: "synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "associated with purified microtubules."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0026046:Microtubules [Cell Component]
   770   C1998793:Purified [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.92: View larger version (149K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(149K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.93: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.94: Electron microscopic immunonegative staining of purified rat microtubules. a-f, the rat microtubules were incubated with different primary antibodies, and the immunoreactions were visualized using 10-nm immunogold particles. 

Phrase: "Electron microscopic immunonegative staining of purified rat microtubules. a-f,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0487602:Staining [Laboratory Procedure]
   739   C1704680:Staining [Finding]

Phrase: "the rat microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026046:Microtubules [Cell Component]

Phrase: "were"

Phrase: "incubated with different primary antibodies,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1705242:Different [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "the immunoreactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0872193:immunoreaction [Organism Function]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "10-nm immunogold particles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597177:particles [Chemical Viewed Structurally]
Processing 00000000.tx.95: Anti--tubulin (a), TAU-2 (b), MDV2 (c), PQE3 (d), and REE1 (e) labeled the microtubules, but anti-A did not (f). 

Phrase: "Anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "("

Phrase: "a"

Phrase: ")"

Phrase: ","

Phrase: "TAU-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "MDV2"

Phrase: "(c), PQE3"

Phrase: "("

Phrase: "d)"

Phrase: ","

Phrase: "and"

Phrase: "REE1"

Phrase: "(e)"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "the microtubules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "but"

Phrase: "anti-A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not (f)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.96: Bar represents 100nm. 

Phrase: "Bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "100nm."
Processing 00000000.tx.97: Tubulin Stimulates -Synuclein Fibril Formation-- To prove the involvement of tubulin in the fibril formation of -synuclein, solutions with -synuclein concentrations ranging from 0to 700M were incubated in the presence or absence of 1M tubulin in PBS at 37C. 

Phrase: "Tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "Stimulates -"

Phrase: "Synuclein Fibril Formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prove"

Phrase: "the involvement of tubulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "in the fibril formation of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "solutions with -synuclein concentrations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0037633:Solutions [Substance]
   761   C1707468:Concentrated Solution [Biomedical or Dental Material]
   737 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "ranging from 0to 700M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "were"

Phrase: "incubated in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "absence of 1M tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "at 37C."
Processing 00000000.tx.98: Purified tubulin was analyzed by SDS-PAGE (silver stain) and immunoblotting and was confirmed to be free from microtubule-associated proteins, such as tau or MAP5 (MAP1b) (not shown). 

Phrase: "Purified tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "was"

Phrase: "analyzed by SDS-PAGE (silver stain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   790   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   753   C0037125:Silver [Element, Ion, or Isotope]
   753   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   753   C0936012:Analyzed [Research Activity]
   753   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   753   C1305285:Silver [Qualitative Concept]
   753   C1704732:Page [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "and"

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "free from microtubule-associated proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332296:free [Functional Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "such as tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "or"

Phrase: "MAP5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0250759:MAP5 [Amino Acid, Peptide, or Protein]
  1000   C1417004:MAP5 [Gene or Genome]

Phrase: "(MAP1b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0250759:MAP1B [Amino Acid, Peptide, or Protein]
  1000   C1417004:MAP1B [Gene or Genome]

Phrase: ")"

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.99: It is possible that oligomers of tubulin are more effective in acting as seeds for -synuclein fibrillogenesis. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that oligomers of tubulin"

Phrase: "are"

Phrase: "more effective in acting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:effective [Qualitative Concept]
   770   C1704419:Effective [Qualitative Concept]

Phrase: "as"

Phrase: "seeds for -synuclein fibrillogenesis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0036563:Seed [Plant]
   770   C1705192:Seed [Laboratory Procedure]
   770   C1882540:{Seed} [Quantitative Concept]
   770   C2346495:Seed [Conceptual Entity]
   715 E C1519232:Seminal [Clinical Attribute]
Processing 00000000.tx.100: To test this potential, microtubule assembling cofactors, such as MgCl2 and GTP, were added in a separate reaction at minimal concentrations (the commonly used concentrations times 103), and the fibril formation was found to be accelerated by these cofactors (Fig. 4, a and b). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this potential,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:Potential [Qualitative Concept]

Phrase: "microtubule assembling cofactors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0178555:cofactors [Biologically Active Substance]

Phrase: "such as MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "added in a separate reaction"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0443286:Reaction [Functional Concept]
   760   C0443299:Separate [Spatial Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "at minimal concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "the commonly used concentrations times 103"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   804   C0040223:times [Temporal Concept]
   804   C0086045:Concentrations [Mental Process]
   804   C1273517:used [Finding]
   804   C1632851:Times [Quantitative Concept]
   771 E C1446561:Concentration [Quantitative Concept]
   771 E C3541383:Time [Temporal Concept]
   733 E C0442043:Temporal [Spatial Concept]
   733 E C2362314:Temporal [Temporal Concept]
   721 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "accelerated by these cofactors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178555:cofactors [Biologically Active Substance]
   770   C0521110:Accelerated [Functional Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.101: -Synuclein was assembled into fibrillar structures only in the presence of 1M tubulin as shown by light scattering (Fig. 4, a-c) and by EM (Fig. 4, d-f). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "assembled into fibrillar structures only"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205171:Only [Quantitative Concept]
   760   C0678594:structures [Spatial Concept]
   760   C1720467:Only [Intellectual Product]
   726   C1706853:Assemble [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 1M tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "as"

Phrase: "shown by light scattering"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0596837:Light Scattering [Phenomenon or Process]
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C0439742:Scattering [Spatial Concept]
   770   C1306462:Light [Functional Concept]
   770   C1881376:Light [Qualitative Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a-c)"

Phrase: "and by EM (Fig. 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0349966:Fig [Food]
   760   C1337208:FIG [Food]
   760   C1515981:And [Idea or Concept]

Phrase: "d-"

Phrase: "f)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.102: Over the course of several hours filaments 10nm in diameter and about 1m in length were formed (Fig. 4d). 

Phrase: "Over the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of several hours filaments 10nm"

Phrase: "in diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1301886:Diameter [Quantitative Concept]

Phrase: "and about 1m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0470296:1M [Quantitative Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "in length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "were"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "(Fig. 4d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.103: -Synuclein fibrils thus produced were examined by immuno-EM with anti--synuclein antibodies MDV2 (not shown), EQV1 (Fig. 4e), and PQE3 (not shown), which were previously used to study LBs in Parkinson's disease (9) and GCIs in MSA (10). 

Phrase: "-Synuclein fibrils thus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "produced"

Phrase: "were"

Phrase: "examined by immuno-EM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0079835:Microscopy, Immuno-Electron [Diagnostic Procedure]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0332128:Examined [Finding]

Phrase: "with anti"

Phrase: "--"

Phrase: "synuclein antibodies MDV2"

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "EQV1"

Phrase: "(Fig. 4e"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "PQE3"

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "were"

Phrase: "previously"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "LBs in Parkinson's disease"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   874   C0030567:Lewy Body Parkinson Disease [Disease or Syndrome]
   835   C0752347:bodies disease lewy [Disease or Syndrome]
   806   C0085200:Lewy Bodies [Cell Component]
   760   C0242821:bodies [Human]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1268086:Body [Anatomical Structure]

Phrase: "(9"

Phrase: ")"

Phrase: "and"

Phrase: "GCIs in MSA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C3548440:glial cytoplasmic inclusion [Cell Component]
   778   C0205708:Cytoplasmic Inclusions [Cell Component]
   748   C0010834:Cytoplasmic [Cell Component]
   748   C0521449:Cytoplasmic [Body Location or Region]
   714   C1512693:Inclusion [Qualitative Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.104: These filaments were also decorated with anti--tubulin (Fig. 4f) and anti--tubulin (not shown), but not with negative controls, such as anti--synuclein REE1 (not shown) or anti-A (not shown). 

Phrase: "These filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "decorated with anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2937342:tubulin [Cell Component]

Phrase: "(Fig. 4f"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450379:4f [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not with negative controls,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   799   C1639518:% negative control [Quantitative Concept]
   799   C1947986:Negative Control [Conceptual Entity]
   770   C0205160:Negative [Qualitative Concept]
   770   C1513916:Negative [Finding]
   770   C1518422:Not [Functional Concept]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "such as anti"

Phrase: "--"

Phrase: "synuclein REE1"

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "anti-A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: The dimensions and morphology of these structures are similar to those of -synuclein filaments in the brain sections of Parkinson's disease (9) (Fig. 4g). 

Phrase: "The dimensions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439534:Dimensions [Quantitative Concept]
   893 E C1707753:Dimensionality [Spatial Concept]

Phrase: "and"

Phrase: "morphology of these structures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332437:Morphology [Qualitative Concept]
   770   C0543482:morphology [Spatial Concept]
   770   C0700329:Morphology, NOS [Finding]
   770   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "are"

Phrase: "similar to those of -synuclein filaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "in the brain sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "of Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(9"

Phrase: ")"

Phrase: "(Fig. 4g"

Phrase: ")."
Processing 00000000.tx.106: -Synuclein filaments were produced only in the presence of 1M tubulin (Fig. 4, a-d) not in solutions containing -synuclein alone (Fig. 4c; C1) or in other controls (Fig. 4c; C2, C3, and C4). 

Phrase: "-Synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "were"

Phrase: "produced"

Phrase: "only in the presence of 1M tubulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205171:Only [Quantitative Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0470296:1M [Quantitative Concept]
   748   C1720467:Only [Intellectual Product]
   748   C2937342:tubulin [Cell Component]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a-d)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "not in solutions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0037633:Solutions [Substance]
   790   C1518422:Not [Functional Concept]
   756 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 4c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "; C1)"

Phrase: "or in other controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 4c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "; C2,"

Phrase: "C3,"

Phrase: "and"

Phrase: "C4"

Phrase: ")."
Processing 00000000.tx.107: It is notable that the additives alone were not able to stimulate production of -synuclein fibrils (not shown) but enhanced the fibril production in the presence of tubulin. 

Phrase: "It"

Phrase: "is"

Phrase: "notable"

Phrase: "that"

Phrase: "the additives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0442796:Additives [Qualitative Concept]
   966 E C1550602:Additive [Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "were"

Phrase: "not able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1518422:Not [Functional Concept]

Phrase: "stimulate"

Phrase: "production of -synuclein fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0225328:fibrils [Cell Component]
   779 E C1948066:Fibril [Physical Object]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "but"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the fibril production in the presence of tubulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033268:production [Occupational Activity]
Processing 00000000.tx.108: The morphology of the fibrils produced in the presence of tubulin with additives was identical (not shown) to the morphology of fibrils produced without additives (Fig. 4, d-f). 

Phrase: "The morphology of the fibrils"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332437:Morphology [Qualitative Concept]
   760   C0543482:morphology [Spatial Concept]
   760   C0700329:Morphology, NOS [Finding]
   760   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "produced in the presence of tubulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C2937342:tubulin [Cell Component]

Phrase: "with additives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0442796:Additives [Qualitative Concept]
   966 E C1550602:Additive [Substance]

Phrase: "was"

Phrase: "identical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "to the morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "of fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "produced without additives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0442796:Additives [Qualitative Concept]
   756 E C1550602:Additive [Substance]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "d-"

Phrase: "f)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.109: These results indicate that tubulin is able to induce and promote -synuclein fibril formation under physiological conditions in vitro. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "and"

Phrase: "promote -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "synuclein fibril formation under physiological conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.110: View larger version (96K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(96K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.111: 4.  

Phrase: "4."
Processing 00000000.tx.112: A small amount of tubulin can initiate and promote fibril formation of -synuclein under physiological conditions in vitro. 

Phrase: "A small amount of tubulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "can"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "and"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "fibril formation of -synuclein under physiological conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.113: Solutions of -synuclein (0-700 M) in 25l of PBS were incubated at 37C with a fixed concentration (1M) of tubulin. 

Phrase: "Solutions of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(0-700"

Phrase: "M) in 25l of PBS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "with a fixed concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: ")"

Phrase: "of tubulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]
Processing 00000000.tx.114: In a separate reaction, 1M each MgCl2 and GTP were used as cofactors to induce formation of oligomers of tubulin (see text). 

Phrase: "In a separate reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470296:1M [Quantitative Concept]

Phrase: "each MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "GTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "used as cofactors to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0178555:cofactors [Biologically Active Substance]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "formation of oligomers of tubulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.115: Control experiments were performed by incubating either -synuclein or tubulin alone, with or without BSA (300or 1M). 

Phrase: "Control experiments"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009932:control experiments [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0681814:Experiments [Research Activity]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed by incubating either -synuclein"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1550369:Performed By [Qualitative Concept]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0884358:Performed [Functional Concept]
   760   C1439852:incubating [Laboratory Procedure]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "or"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "with"

Phrase: "or without BSA (300or 1M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470296:1M [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.116: The ordinate represents the relative amount of -synuclein aggregates shown as A400 nm, and the abscissa in a represents time, and in b and c the concentration of -synuclein. 

Phrase: "The ordinate"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the relative amount of -synuclein aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205418:aggregates [Qualitative Concept]

Phrase: "shown as A400 nm,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0312860:NM [Cell Function]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "the abscissa in a"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and in b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "c"

Phrase: "the concentration of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.117: The value represents the average of three determinations. a, the amount of -synuclein aggregates was measured by quasi-elastic light scattering methods using 1l of each reaction mixture at 400nm with a spectrophotometer (Hitachi, Gene Spec III). 

Phrase: "The value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the average of three determinations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]

Phrase: "a,"

Phrase: "the amount of -synuclein aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205418:aggregates [Qualitative Concept]

Phrase: "was"

Phrase: "measured by quasi-elastic light scattering methods"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   853   C1882368:Quasi-Elastic Light Scattering [Laboratory Procedure]
   778   C0596837:Light Scattering [Phenomenon or Process]
   748   C0023693:Light [Natural Phenomenon or Process]
   748   C0025663:Methods [Intellectual Product]
   748   C0025664:methods [Intellectual Product]
   748   C0439742:Scattering [Spatial Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0449851:Methods [Functional Concept]
   748   C0681018:elastic [Functional Concept]
   748   C1306462:Light [Functional Concept]
   748   C1881376:Light [Qualitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C0871511:METHOD [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1l of each reaction mixture"

Phrase: "at 400nm"

Phrase: "with a spectrophotometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183400:Spectrophotometer [Medical Device]

Phrase: "(Hitachi,"

Phrase: "Gene Spec III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.118: -Synuclein and tubulin at a molar ratio of 300:1 in the presence or absence of cofactors, including four controls (C1-C4), were incubated. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "tubulin at a molar ratio of 300"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C2937342:tubulin [Cell Component]

Phrase: ":"

Phrase: "1 in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "or"

Phrase: "absence of cofactors,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "four controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(C1-C4"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "incubated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.119: The light scattering was monitored at various times (0,6,12,24,48,72,and 96h). 

Phrase: "The light scattering"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0596837:Light Scattering [Phenomenon or Process]
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0439742:Scattering [Spatial Concept]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "was"

Phrase: "monitored at various times"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0040223:times [Temporal Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1632851:Times [Quantitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
   737 E C3541383:Time [Temporal Concept]

Phrase: "(0,"

Phrase: "6,"

Phrase: "12,"

Phrase: "24,"

Phrase: "48,"

Phrase: "72,"

Phrase: "and"

Phrase: "96h"

Phrase: ")."
Processing 00000000.tx.120: The filamentous structures began to form after 6h of incubation, and this formation steadily increased and reached a plateau in 3days. 

Phrase: "The filamentous structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form after 6h of incubation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1292428:6H [Temporal Concept]
   760   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "this formation steadily"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "a plateau in 3days."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2964353:Plateau [Quantitative Concept]
Processing 00000000.tx.121: b, different concentrations of -synuclein containing 1M tubulin were incubated for 1week and the light scattering (A400 nm) was determined as described in a. 

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "different concentrations of -synuclein containing 1M tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C2937342:tubulin [Cell Component]

Phrase: "were"

Phrase: "incubated for 1week"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "the light scattering"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0596837:Light Scattering [Phenomenon or Process]
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0439742:Scattering [Spatial Concept]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "(A400 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "was"

Phrase: "determined"

Phrase: "as"

Phrase: "described in a."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.122: The highest amount of assembly was observed in the presence of cofactors (CFs). 

Phrase: "The highest amount of assembly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "observed in the presence of cofactors (CFs)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0178555:cofactors [Biologically Active Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]
Processing 00000000.tx.123: The amount of aggregates was proportional to the concentration of -synuclein. 

Phrase: "The amount of aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "proportional to the concentration of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205351:Proportional [Qualitative Concept]
Processing 00000000.tx.124: In a and b, an open square represents four kinds of controls that were completely flat as shown in c. c, bar graphs of the data obtained in the experiment described in b. 

Phrase: "In a"

Phrase: "and"

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "an open square"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205120:Square [Spatial Concept]
   861   C1552595:Square [Intellectual Product]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "four kinds of controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0332307:Kind [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "completely flat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205324:Flat [Spatial Concept]
   861   C0457933:Flat [Manufactured Object]

Phrase: "as"

Phrase: "shown in c. c,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "bar graphs of the data"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681493:graphs [Intellectual Product]
   726 E C2698021:Graph [Conceptual Entity]

Phrase: "obtained in the experiment"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1301820:Obtained [Functional Concept]
   770   C1706386:Experiment [Conceptual Entity]
   737 E C1706701:Obtain [Activity]

Phrase: "described in b."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.125: Tubulin can promote the fibrillogenesis of -synuclein (open columns), and the presence of cofactors accelerates the process (gray columns). 

Phrase: "Tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "can"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the fibrillogenesis of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(open columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the presence of cofactors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "(gray columns"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0556636:gray [Quantitative Concept]
   861   C1269776:Gray [Qualitative Concept]
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.126: Controls; 

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.127: C1: 300M -synuclein; 

Phrase: "C1"

Phrase: ":"

Phrase: "300M -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.128: C2: 1M tubulin; 

Phrase: "C2"

Phrase: ":"

Phrase: "1M tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: ";"
Processing 00000000.tx.129: C3: 300M -synuclein+1M BSA; 

Phrase: "C3"

Phrase: ":"

Phrase: "300M -synuclein+1M BSA"

Phrase: ";"
Processing 00000000.tx.130: C4: 300M BSA+1M tubulin. 

Phrase: "C4"

Phrase: ":"

Phrase: "300M BSA+1M tubulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2937342:tubulin [Cell Component]
Processing 00000000.tx.131: Different concentrations (100-700 M) of -synuclein plus 1M tubulin. d, an electron micrograph of representative filamentous aggregates of this polymerization reaction. 

Phrase: "Different concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(100-700"

Phrase: "M)"

Phrase: "of -synuclein plus 1M tubulin. d,"

Phrase: "an electron micrograph of representative filamentous aggregates of this polymerization reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0013852:Electron [Quantitative Concept]
   738   C3463986:Electron [Bird]
Processing 00000000.tx.132: A number of long, 10-nm-wide, amyloid-like filaments were formed. 

Phrase: "A number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of long, 10-nm-wide, amyloid-like filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   762   C0010851:Filament [Cell Component]
   712 E C1979891:Filamentous [Qualitative Concept]

Phrase: "were"

Phrase: "formed."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]
Processing 00000000.tx.133: Bar represents 100nm. 

Phrase: "Bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "100nm."
Processing 00000000.tx.134: e and f, isolated filaments immunolabeled with EQV1 and anti--tubulin antibodies, respectively. 

Phrase: "e"

Phrase: "and"

Phrase: "f,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "isolated filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "immunolabeled with EQV1"

Phrase: "and"

Phrase: "anti--tubulin antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.135: Bar represents 100nm. 

Phrase: "Bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "100nm."
Processing 00000000.tx.136: g, filaments of Lewy bodies are 9-10 nm in diameter in post-embedding EM, labeled with PQE3 and probed by 5-nm diameter immunogold particles. 

Phrase: "g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "filaments of Lewy bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0010851:Filament [Cell Component]

Phrase: "are"

Phrase: "9-10 nm in diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "in post-embedding EM,"

Phrase: "labeled with PQE3"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "probed by 5-nm diameter immunogold particles."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0312860:NM [Cell Function]
   748   C0597177:particles [Chemical Viewed Structurally]
   748   C1301886:Diameter [Quantitative Concept]
   714   C0182400:Probe [Medical Device]
   714   C1704681:Probe [Gene or Genome]
   714   C2347609:Probe [Chemical Viewed Functionally]
   714   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.137: Tubulin Co-localizes with Pathological Structures of -Synuclein-- We subsequently investigated the in vivo co-localization of tubulin and -synuclein in LBs in the dorsal motor nucleus of the vagus nerve of a patient with Parkinson's disease and cervical sympathetic ganglia of that with DLB, as well as in GCIs of that with MSA using double labeling immunofluorescence methods. 

Phrase: "Tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "Co-localizes with Pathological Structures of -Synuclein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0030664:Pathological [Biomedical Occupation or Discipline]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392752:localize [Spatial Concept]
   748   C0678594:structures [Spatial Concept]
   748   C1521733:Pathological [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "We subsequently"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the in vivo co-localization of tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "and -"

Phrase: "synuclein in LBs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the dorsal motor nucleus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0596458:Dorsal Motor Nucleus [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]
   827   C0205095:Dorsal [Spatial Concept]
   827   C1513492:Motor [Functional Concept]
   827   C1705994:Motor [Manufactured Object]

Phrase: "of the vagus nerve"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0042276:Vagus Nerve [Body Part, Organ, or Organ Component]
           Vagus
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "of a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "cervical sympathetic ganglia of that"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   845   C0446846:Cervical sympathetic ganglion [Body Part, Organ, or Organ Component]
           Cervical ganglia
   806   C0017071:Sympathetic Ganglia [Body Part, Organ, or Organ Component]
   760   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   726 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "with DLB,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   888   C0752347:dementia lewy bodies [Disease or Syndrome]
   840   C0085200:Lewy Bodies [Cell Component]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0242821:bodies [Human]
   804   C0332287:With [Qualitative Concept]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   804   C1705690:With [Intellectual Product]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "as well as in GCIs of that"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   773   C3548440:glial cytoplasmic inclusion [Cell Component]
   764   C0205708:Cytoplasmic Inclusions [Cell Component]
   742   C0010834:Cytoplasmic [Cell Component]
   742   C0027836:Glial [Cell]
   742   C0205170:Well [Qualitative Concept]
   742   C0521449:Cytoplasmic [Body Location or Region]
   742   C3146287:Well [Manufactured Object]
   708   C1512693:Inclusion [Qualitative Concept]

Phrase: "with MSA"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "double labeling immunofluorescence methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.138: The rhodamine-labeled anti--synuclein antibody (PQE3) decorated LBs, pale bodies, Lewy-related neurites, and GCIs intensely (Fig. 5, a, d, and g). 

Phrase: "The rhodamine-labeled anti"

Phrase: "--"

Phrase: "synuclein antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(PQE3"

Phrase: ")"

Phrase: "decorated LBs,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0085200:Lewy Bodies [Cell Component]
   827   C0242821:bodies [Human]
   827   C1995017:Bodies [Cell Component]
   793 E C0460148:Body [Anatomical Structure]
   793 E C1268086:Body [Anatomical Structure]

Phrase: "pale bodies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C3546242:pale body [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "Lewy-related neurites,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C3548404:Lewy neurite [Cell Component]
   827   C0085103:Neurites [Cell Component]

Phrase: "and"

Phrase: "GCIs intensely"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   906   C3548440:glial cytoplasmic inclusion [Cell Component]
   861   C0205708:Cytoplasmic Inclusions [Cell Component]
   812   C0010834:Cytoplasmic [Cell Component]
   812   C0521449:Cytoplasmic [Body Location or Region]
   779   C1512693:Inclusion [Qualitative Concept]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a,"

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.139: FITC-tagged anti--tubulin stained these structures as well (Fig. 5, c, f, and i). 

Phrase: "FITC-tagged anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2937342:tubulin [Cell Component]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "these structures as well"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:structures [Spatial Concept]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "c,"

Phrase: "f,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.140: These signals overlapped completely or partially when merged (Fig. 5, b, e, and h). 

Phrase: "These signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "overlapped"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0185027:overlapped [Therapeutic or Preventive Procedure]
   966 E C1948020:Overlap [Conceptual Entity]

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "or"

Phrase: "partially"

Phrase: "when"

Phrase: "merged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881786:Merged [Activity]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "e,"

Phrase: "and"

Phrase: "h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.141: -Tubulin was also detected in these pathological structures by a similar method (not shown). 

Phrase: "-Tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "was"

Phrase: "also"

Phrase: "detected in these pathological structures"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0030664:Pathological [Biomedical Occupation or Discipline]
   760   C0442726:Detected [Finding]
   760   C0678594:structures [Spatial Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1521733:Pathological [Functional Concept]

Phrase: "by a similar method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.142: View larger version (51K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(51K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.143: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.144: -Tubulin co-localizes with -synuclein in cytoplasmic inclusions. 

Phrase: "-Tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "co-localizes with -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392752:localize [Spatial Concept]

Phrase: "in cytoplasmic inclusions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205708:Cytoplasmic Inclusions [Cell Component]
   861   C0010834:Cytoplasmic [Cell Component]
   861   C0521449:Cytoplasmic [Body Location or Region]
   827   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.145: A double labeling immunofluorescence study of brain tissues demonstrated co-localization of -tubulin and -synuclein (PQE3) epitopes. a, d, and g, PQE3 is labeled with rhodamine and shown in red. c, f, and i, -tubulin is detected by the FITC-tagged secondary antibody and shown in green. b, e, and h, when the two signals are merged, the overlap is indicated by yellow signals. 

Phrase: "A double labeling immunofluorescence study of brain tissues"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0016318:Immunofluorescence [Laboratory Procedure]
   744   C0079603:Immunofluorescence [Laboratory Procedure]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "co-localization of -tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2937342:tubulin [Cell Component]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(PQE3"

Phrase: ")"

Phrase: "epitopes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitopes [Immunologic Factor]

Phrase: "a,"

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "PQE3"

Phrase: "is"

Phrase: "labeled with rhodamine"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "shown in red. c,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332575:Red [Finding]
   770   C1260956:Red [Qualitative Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "f,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "i, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "is"

Phrase: "detected by the FITC-tagged secondary antibody"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0027627:secondary [Neoplastic Process]
   748   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1708632:Tagged [Qualitative Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "shown in green. b,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332583:Green [Qualitative Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "e,"

Phrase: "and"

Phrase: "h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "when"

Phrase: "the two signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "merged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881786:Merged [Activity]

Phrase: ","

Phrase: "the overlap"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:overlap [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlap [Conceptual Entity]

Phrase: "is"

Phrase: "indicated by yellow signals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0221205:Yellow [Qualitative Concept]
   770   C1444656:Indicated [Finding]
   737   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.146: Dual immunolabeling was demonstrated in Lewy bodies (arrows), pale bodies (double arrows), Lewy-related neurites (arrowheads) in the dorsal motor nucleus of the vagus nerve of a patient with Parkinson's disease (a-c), and in the cervical sympathetic ganglia of that with dementia with Lewy bodies (d-f), as well as in glial cytoplasmic inclusions (arrows) of that with multiple system atrophy (g-i). 

Phrase: "Dual immunolabeling"

Phrase: "was"

Phrase: "demonstrated in Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "pale bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C3546242:pale body [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "(double arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "Lewy-related neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C3548404:Lewy neurite [Cell Component]
   827   C0085103:Neurites [Cell Component]

Phrase: "(arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")"

Phrase: "in the dorsal motor nucleus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0596458:Dorsal Motor Nucleus [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]
   827   C0205095:Dorsal [Spatial Concept]
   827   C1513492:Motor [Functional Concept]
   827   C1705994:Motor [Manufactured Object]

Phrase: "of the vagus nerve"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0042276:Vagus Nerve [Body Part, Organ, or Organ Component]
           Vagus
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "of a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(a-c),"

Phrase: "and in the cervical sympathetic ganglia of that"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C0446846:Cervical sympathetic ganglion [Body Part, Organ, or Organ Component]
           Cervical ganglia
   770   C0017071:Sympathetic Ganglia [Body Part, Organ, or Organ Component]
   744   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   744   C0027530:Cervical [Body Location or Region]
   744   C0205064:Cervical [Spatial Concept]
   744   C1515981:And [Idea or Concept]
   711 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "with dementia with Lewy bodies"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   888   C0752347:dementia lewy bodies [Disease or Syndrome]
   840   C0085200:Lewy Bodies [Cell Component]
   804   C0011265:dementia [Mental or Behavioral Dysfunction]
   804   C0242821:bodies [Human]
   804   C0332287:With [Qualitative Concept]
   804   C0497327:Dementia [Mental or Behavioral Dysfunction]
   804   C1705690:With [Intellectual Product]
   804   C1995017:Bodies [Cell Component]
   771 E C0460148:Body [Anatomical Structure]
   771 E C1268086:Body [Anatomical Structure]
   704 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "("

Phrase: "d-"

Phrase: "f),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "as well as in glial cytoplasmic inclusions"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C3548440:glial cytoplasmic inclusion [Cell Component]
   778   C0205708:Cytoplasmic Inclusions [Cell Component]
   748   C0010834:Cytoplasmic [Cell Component]
   748   C0027836:Glial [Cell]
   748   C0205170:Well [Qualitative Concept]
   748   C0521449:Cytoplasmic [Body Location or Region]
   748   C3146287:Well [Manufactured Object]
   714   C1512693:Inclusion [Qualitative Concept]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "of that"

Phrase: "with multiple system atrophy"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(g-i)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0086706:G I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.147: Bar represents 10m.  

Phrase: "Bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "10m."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]
Processing 00000000.tx.148: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The discovery of two missense mutations in the -synuclein gene in certain autosomal dominant familial Parkinson's disease pedigrees (6, 7) suggested a pivotal role of -synuclein in the onset and progression of Parkinson's disease. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The discovery of two missense mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880355:Discovery [Activity]

Phrase: "in the -synuclein gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "in certain autosomal dominant familial Parkinson's disease pedigrees"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0030761:pedigrees [Intellectual Product]
   708   C3489791:Parkinson Disease, Autosomal Dominant [Disease or Syndrome]

Phrase: "(6,"

Phrase: "7"

Phrase: ")"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a pivotal role of -synuclein in the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "progression of Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0242656:Disease Progression [Pathologic Function]
           progression
   819   C1947900:Disease progression NOS [Finding]
   770   C0449258:Progression [Functional Concept]
Processing 00000000.tx.149: This has been substantiated by the following findings. 

Phrase: "This"

Phrase: "has"

Phrase: "been"

Phrase: "substantiated by the following findings."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
   726 E C2825141:Finding [Finding]
Processing 00000000.tx.150: (i) Anti--synuclein antibodies detect the major filamentous component of LBs, Lewy-related neurites, and pale bodies (a possible early phase of LB-formation) (9) in Parkinson's disease and DLB (8, 9) and LB variant of Alzheimer's disease (23, 24). 

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Anti"

Phrase: "--"

Phrase: "synuclein antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the major filamentous component of LBs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "Lewy-related neurites,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C3548404:Lewy neurite [Cell Component]
   827   C0085103:Neurites [Cell Component]

Phrase: "and"

Phrase: "pale bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C3546242:pale body [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "("

Phrase: "a possible early phase of LB-formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205390:Phase [Temporal Concept]

Phrase: ")"

Phrase: "(9"

Phrase: ")"

Phrase: "in Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "DLB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(8,"

Phrase: "9"

Phrase: ")"

Phrase: "and"

Phrase: "LB variant of Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variant [Qualitative Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.151: (ii) Insoluble -synuclein filaments are recovered from DLB brains (25). 

Phrase: "(ii"

Phrase: ")"

Phrase: "Insoluble -synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]

Phrase: "are"

Phrase: "recovered from DLB brains"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   853   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0006104:Brains [Body Part, Organ, or Organ Component]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0242821:bodies [Human]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C0521108:recovered [Qualitative Concept]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]
   714 E C1269537:Brain [Body Part, Organ, or Organ Component]
   714 E C2004454:recover [Organism Function]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.152: (iii) Recombinant -synuclein forms LB-like filaments (26), and familial Parkinson's disease mutations accelerate the fibril formation (13, 14). 

Phrase: "(iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "Recombinant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "LB-like filaments"

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "familial Parkinson's disease mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
   708   C0277558:Familial disease [Disease or Syndrome]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "the fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.153: Because familial Parkinson's disease patients are rare, unknown epigenetic factors may induce fibril formation of wild-type -synuclein, leading to pathological structures such as LBs. 

Phrase: "Because"

Phrase: "familial Parkinson's disease patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030705:Patients [Patient or Disabled Group]
   708   C0277558:Familial disease [Disease or Syndrome]

Phrase: "are"

Phrase: "rare, unknown epigenetic factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "fibril formation of wild-type -synuclein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "leading to pathological structures"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0030664:Pathological [Biomedical Occupation or Discipline]
   770   C0332152:Leading [Temporal Concept]
   770   C0678594:structures [Spatial Concept]
   770   C1521733:Pathological [Functional Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "such as LBs."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.154: In this study, we searched for potential intrinsic factors that may initiate and/or promote fibril formation of -synuclein using an -synuclein column, and we found that tubulin was one of the -synuclein-binding/associated proteins. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "searched for potential intrinsic factors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0021918:intrinsic factors [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205102:Intrinsic [Spatial Concept]
   760   C0439674:Intrinsic [Functional Concept]
   760   C1706202:Searched [Activity]
   760   C3245505:Potential [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726 E C1552603:search [Intellectual Product]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "and/or"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "fibril formation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an -synuclein column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "and"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "was"

Phrase: "one of the -synuclein-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "/associated proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.155: Co-localization of tubulin with -synuclein in LBs and other pathological structures suggested that tubulin might be such a factor. 

Phrase: "Co-localization of tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "other pathological structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "might"

Phrase: "be"

Phrase: "such a factor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.156: Employing affinity column chromatography using recombinant -synuclein and human brain proteins, -tubulin was identified as an -synuclein-binding/associated protein. 

Phrase: "Employing affinity column chromatography"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   875   C0008551:Chromatography, Affinity [Laboratory Procedure]
   861   C0684296:Column Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]
   712 E C0302647:chromatograph [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "recombinant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "human brain proteins, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "was"

Phrase: "identified as an -synuclein-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "/associated protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.157: Both the and subunits of tubulin were equally co-immunoprecipitated with endogenous -synuclein in the cytoplasmic fraction of rat brain, which is consistent with a notion that -tubulin forms a heterodimer with -tubulin. 

Phrase: "Both"

Phrase: "the"

Phrase: "and"

Phrase: "subunits of tubulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1711351:Subunit [Quantitative Concept]

Phrase: "were"

Phrase: "equally"

Phrase: "co-immunoprecipitated with endogenous -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205227:Endogenous [Functional Concept]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "in the cytoplasmic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "of rat brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "is"

Phrase: "consistent with a notion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that -tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a heterodimer with -tubulin."
Processing 00000000.tx.158: The interaction between -synuclein and tubulin was confirmed by copurification of both - and -synucleins with microtubules. 

Phrase: "The interaction between -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "was"

Phrase: "confirmed by copurification of both -"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0750484:Confirmed [Idea or Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "and -"

Phrase: "synucleins with microtubules."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.159: Immuno-EM studies clearly showed the association of both - and -synucleins with purified microtubules as has also been shown for other microtubule-associated proteins such as tau. 

Phrase: "Immuno-EM"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "clearly"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the association of both -"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and -"

Phrase: "synucleins with purified microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown for other microtubule-associated proteins"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0026045:Microtubule-Associated Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0026042:Microtubule Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0026046:Micro-tubule [Cell Component]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332281:Associated [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719   C1547282:Show [Intellectual Product]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "such as tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]
Processing 00000000.tx.160: These results suggest that tubulin may be a physiological binding partner of -synuclein. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "may"

Phrase: "be"

Phrase: "a physiological binding partner of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.161: However, until the binding affinities are known, it cannot be certain that this interaction between tubulin and -synuclein is physiologically meaningful. 

Phrase: "However,"

Phrase: "until"

Phrase: "the binding affinities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "it"

Phrase: "cannot"

Phrase: "be"

Phrase: "certain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205423:Certain [Qualitative Concept]
  1000   C1704787:Certain [Qualitative Concept]
   928 E C0439543:Certainties [Qualitative Concept]

Phrase: "that"

Phrase: "this interaction between tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C3537022:Tubulin Interaction [Molecular Function]
   770   C1704675:Interaction [Functional Concept]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "physiologically meaningful."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0876919:Meaning [Idea or Concept]
Processing 00000000.tx.162: Further studies will be needed to know the physiological role of -synuclein in association with tubulin. 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "will"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "know"

Phrase: "the physiological role of -synuclein in association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with tubulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]
Processing 00000000.tx.163: Because the brain is a rich source of tubulin, we speculate that the interaction between -synuclein and free tubulin may occur in vivo and that under pathological conditions tubulin might initiate and promote the fibril formation of -synuclein, leading to pathological structures such as LBs. 

Phrase: "Because"

Phrase: "the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "a rich source of tubulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "we"

Phrase: "speculate"

Phrase: "that"

Phrase: "the interaction between -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "free tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "may"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "that under pathological conditions tubulin"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0030664:Pathological [Biomedical Occupation or Discipline]
   760   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1521733:Pathological [Functional Concept]
   760   C2937342:tubulin [Cell Component]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "might"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "and"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the fibril formation of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "leading to pathological structures"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0030664:Pathological [Biomedical Occupation or Discipline]
   770   C0332152:Leading [Temporal Concept]
   770   C0678594:structures [Spatial Concept]
   770   C1521733:Pathological [Functional Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "such as LBs."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.164: To test this hypothesis we performed in vitro studies, which showed that -synuclein fibril formation was in fact initiated and promoted by tubulin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in vitro studies,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that -synuclein fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "was in fact"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "and"

Phrase: "promoted by tubulin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2937342:tubulin [Cell Component]
   756   C0033414:Promote [Activity]
Processing 00000000.tx.165: Most importantly, these -synuclein fibrils were produced only in the presence of a small amount of tubulin under physiological conditions. 

Phrase: "Most importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "these -synuclein fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "produced"

Phrase: "only in the presence of a small amount of tubulin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205171:Only [Quantitative Concept]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0700321:Small [Quantitative Concept]
   739   C1265611:Amount [Quantitative Concept]
   739   C1720467:Only [Intellectual Product]
   739   C2937342:tubulin [Cell Component]

Phrase: "under physiological conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.166: Immuno-EM studies revealed that the dimensions and morphology of these fibrils made in vitro closely resembled those of the -synuclein filaments observed in autopsied brain sections of Parkinson's disease and were obviously different from those of microtubules. 

Phrase: "Immuno-EM studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the dimensions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439534:Dimensions [Quantitative Concept]
   893 E C1707753:Dimensionality [Spatial Concept]

Phrase: "and"

Phrase: "morphology of these fibrils"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332437:Morphology [Qualitative Concept]
   770   C0543482:morphology [Spatial Concept]
   770   C0700329:Morphology, NOS [Finding]
   770   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "in vitro closely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]

Phrase: "resembled"

Phrase: "those of the -synuclein filaments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0010851:Filament [Cell Component]

Phrase: "observed in autopsied brain sections of Parkinson's disease"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   789   C0006111:Disease of brain, NOS [Disease or Syndrome]
           Brain Disease
   770   C0030567:Parkinson Disease [Disease or Syndrome]
   770   C1521736:Parkinson's Disease [Functional Concept]
   770   C2681933:PARKINSON DISEASE [Gene or Genome]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0012634:Disease [Disease or Syndrome]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1441672:Observed [Functional Concept]
   711   C0004398:Autopsy [Diagnostic Procedure]
   711   C0205155:Section [Spatial Concept]
   711   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   711   C1522472:Section [Substance]
   711   C1552923:Section [Quantitative Concept]
   711   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "were"

Phrase: "obviously different from those of microtubules."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.167: These results indicate that tubulin is capable of seeding the fibril formation of -synuclein. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "is"

Phrase: "capable of seeding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "the fibril formation of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.168: We then investigated the in vivo co-localization of tubulin and -synuclein in autopsied brains using double labeling immunofluorescence, and we showed that both -synuclein and - tubulin epitopes are co-localized in LBs, pale bodies, Lewy-related neurites, and GCIs in the central and peripheral nervous systems. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the in vivo co-localization of tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "and -"

Phrase: "synuclein in autopsied brains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "double labeling immunofluorescence,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0016318:Immunofluorescence [Laboratory Procedure]
   827   C0079603:Immunofluorescence [Laboratory Procedure]
   771 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   755 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "tubulin epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "are"

Phrase: "co-localized in LBs,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0085200:Lewy Bodies [Cell Component]
   760   C0242821:bodies [Human]
   760   C0392752:Localized [Spatial Concept]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1268086:Body [Anatomical Structure]

Phrase: "pale bodies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C3546242:pale body [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "Lewy-related neurites,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C3548404:Lewy neurite [Cell Component]
   827   C0085103:Neurites [Cell Component]

Phrase: "and"

Phrase: "GCIs in the central"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   816   C3548440:glial cytoplasmic inclusion [Cell Component]
   790   C0205708:Cytoplasmic Inclusions [Cell Component]
   753   C0010834:Cytoplasmic [Cell Component]
   753   C0521449:Cytoplasmic [Body Location or Region]
   719   C1512693:Inclusion [Qualitative Concept]

Phrase: "and"

Phrase: "peripheral nervous systems."
Meta Candidates (Total=19; Excluded=9; Pruned=0; Remaining=10)
  1000   C0206417:Systems, Peripheral Nervous [Body System]
   901   C0027763:Systems, Nervous [Body System]
   867 E C0422837:NERVOUS SYSTEM [Finding]
   867 E C1269560:Nervous system [Body System]
   843   C0031119:Peripheral Nerves [Body Part, Organ, or Organ Component]
   843   C1280200:Peripheral nerve [Body Part, Organ, or Organ Component]
   829 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205100:Peripheral [Spatial Concept]
   827   C0599851:Nervous [Functional Concept]
   801 E C0027855:Neurology [Biomedical Occupation or Discipline]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   785 E C2707261:Neurological [Clinical Attribute]
   743 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.169: These results indicate that tubulin co-localizes with pathological structures of -synuclein in Parkinson's disease, DLB, and MSA. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "co-localizes with pathological structures of -synuclein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0030664:Pathological [Biomedical Occupation or Discipline]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392752:localize [Spatial Concept]
   748   C0678594:structures [Spatial Concept]
   748   C1521733:Pathological [Functional Concept]

Phrase: "in Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "DLB,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "MSA."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.170: Tau is a well-characterized MAP, and abnormal aggregates of tau, or tau pathology, are thought to be an early event in the development of neurofibrillary lesions (27, 28). 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "a well-characterized MAP,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   884   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026046:Micro-tubule [Cell Component]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332281:Associated [Qualitative Concept]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "abnormal aggregates of tau,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205418:aggregates [Qualitative Concept]

Phrase: "or"

Phrase: "tau pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an early event in the development of neurofibrillary lesions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0441471:Event [Event]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.171: The C terminus of -synuclein is reported to be reactive with the microtubule binding region of tau (29) and MAP5 (MAP1b) (22). 

Phrase: "The C terminus of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "reactive with the microtubule binding region of tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205332:Reactive [Qualitative Concept]

Phrase: "(29"

Phrase: ")"

Phrase: "and"

Phrase: "MAP5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0250759:MAP5 [Amino Acid, Peptide, or Protein]
  1000   C1417004:MAP5 [Gene or Genome]

Phrase: "(MAP1b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0250759:MAP1B [Amino Acid, Peptide, or Protein]
  1000   C1417004:MAP1B [Gene or Genome]

Phrase: ")"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.172: In our in vitro experiments (Fig. 4) purified tubulin produced -synuclein fibrils in the absence of tau and MAP5 (MAP1b). 

Phrase: "In our in vitro experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "purified tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "produced -"

Phrase: "synuclein fibrils in the absence of tau"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0225328:fibrils [Cell Component]
   714 E C1948066:Fibril [Physical Object]

Phrase: "and"

Phrase: "MAP5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0250759:MAP5 [Amino Acid, Peptide, or Protein]
  1000   C1417004:MAP5 [Gene or Genome]

Phrase: "(MAP1b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0250759:MAP1B [Amino Acid, Peptide, or Protein]
  1000   C1417004:MAP1B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.173: More importantly, tau does not co-localize with -synuclein in LBs in general (30), but tubulin does as shown in Fig. 

Phrase: "More importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "co-localize with -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392752:localize [Spatial Concept]

Phrase: "in LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "in general"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "does"

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.174: 5, suggesting that the interaction between -synuclein and tubulin may not be mediated by tau. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the interaction between -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "mediated by tau."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]
Processing 00000000.tx.175: The precise mechanism of neurodegeneration in Parkinson's disease brain is unknown. 

Phrase: "The precise mechanism of neurodegeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "in Parkinson's disease brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.176: Accumulating evidence suggests that the aggregation of -synuclein may play a critical role in the pathogenesis of Parkinson's disease (31), although the mechanisms by which -synuclein is preferentially aggregated in the Parkinson's disease brain remained elusive. 

Phrase: "Accumulating evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the aggregation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in the pathogenesis of Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the mechanisms by which -synuclein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "preferentially"

Phrase: "aggregated in the Parkinson's disease brain"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0030567:Parkinson Disease [Disease or Syndrome]
   790   C1521736:Parkinson's Disease [Functional Concept]
   790   C2681933:PARKINSON DISEASE [Gene or Genome]
   783   C0006111:Brain Disease [Disease or Syndrome]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332621:Aggregated [Functional Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   719 E C0205418:Aggregate [Qualitative Concept]

Phrase: "remained"

Phrase: "elusive."
Processing 00000000.tx.177: As shown here, tubulin is apparently able to initiate the polymerization of -synuclein, resulting in the formation of -synuclein fibrils, which may eventually lead to pathological structures such as LBs in diseased brains. 

Phrase: "As"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here,"

Phrase: "tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "is"

Phrase: "apparently able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C0750541:apparently [Idea or Concept]
   827   C1299581:Able [Finding]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "the polymerization of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulting in the formation of -synuclein fibrils,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   778   C0332294:Resulting in [Functional Concept]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0220781:formation [Biologic Function]
   748   C0225328:fibrils [Cell Component]
   748   C0439634:formation [Spatial Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1522492:Formation [Functional Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C1948066:Fibril [Physical Object]
   714 E C2825142:Result [Finding]

Phrase: "which"

Phrase: "may"

Phrase: "eventually"

Phrase: "lead to pathological structures"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0030664:Pathological [Biomedical Occupation or Discipline]
   770   C0678594:structures [Spatial Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1521733:Pathological [Functional Concept]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "such as LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "in diseased brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.178: Thus, it is possible that some epigenetic elements (e.g. drugs, chemicals, additives in food, or environmental toxins) may affect the assembly/disassembly equilibrium of microtubules. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "some epigenetic elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "("

Phrase: "e.g. drugs,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "chemicals,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "additives in food,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   858   C0016453:Food Additives [Food]
   790   C0442796:Additives [Qualitative Concept]
   756 E C1550602:Additive [Substance]

Phrase: "or"

Phrase: "environmental toxins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040549:Toxins [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: ")"

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the assembly/disassembly equilibrium of microtubules."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0014653:Equilibrium [Organism Function]
   753   C1547026:Equilibrium [Quantitative Concept]
Processing 00000000.tx.179: Abnormally increased free tubulin thus produced may trigger -synuclein fibril formation. 

Phrase: "Abnormally"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "free tubulin thus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2937342:tubulin [Cell Component]

Phrase: "produced"

Phrase: "may"

Phrase: "trigger -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "synuclein fibril formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.180: If so, those microtubule-disrupting elements can be risk factors for -synuclein-associated degenerative diseases such as Parkinson's disease, DLB, MSA, and LB variant of Alzheimer's disease. 

Phrase: "If"

Phrase: "so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "those microtubule-disrupting elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "can"

Phrase: "be"

Phrase: "risk factors for -synuclein-associated degenerative diseases"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0850664:diseases factors risk [Finding]
   778   C0035648:risk factors [Quantitative Concept]
   778   C1553898:risk factors [Idea or Concept]
   774   C1281905:diseases risk [Finding]
   757   C0679238:disease factors [Functional Concept]
   748   C0035647:Risk [Qualitative Concept]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "such as Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "DLB,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "MSA,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "LB variant of Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.181: Further investigations of the role of tubulin in the aggregation of -synuclein may clarify the mechanisms of neurodegeneration in -synuclein-related diseases.  

Phrase: "Further investigations of the role of tubulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1261322:Investigations [Health Care Activity]
   714 E C1552578:investigation [Idea or Concept]

Phrase: "in the aggregation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the mechanisms of neurodegeneration in -synuclein-related diseases."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441712:Mechanisms [Functional Concept]
   711 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.182: ACKNOWLEDGEMENTS We thank Drs. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.183: Mitsunobu Yoshii, Toshihide Nukada, and Ichiro Sora for valuable comments, Haruko Tonozuka-Uehara for excellent technical assistance, and Yo Shoda and Maho Kato for technical help in photographic work.  

Phrase: "Mitsunobu Yoshii,"

Phrase: "Toshihide Nukada,"

Phrase: "and"

Phrase: "Ichiro Sora for valuable comments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1275624:Sora [Bird]

Phrase: "Haruko Tonozuka-Uehara for excellent technical assistance,"

Phrase: "and"

Phrase: "Yo Shoda"

Phrase: "and"

Phrase: "Maho Kato for technical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
   770   C1551914:Kato [Language]

Phrase: "help in photographic work."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018896:Help [Social Behavior]
   770   C0043227:Work [Occupational Activity]
   770   C1552861:help [Idea or Concept]
Processing 00000000.tx.184: FOOTNOTES * This study was supported by grants from the Ministry of Education, Science and Culture of Japan (to K.A., M.N., and K.U.) and is supported by a fellowship from the Science and Technology Agency of Japan (to M.A.A.).

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Ministry"

Phrase: "of Education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Culture of Japan"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C2242979:Culture [Laboratory Procedure]

Phrase: "("

Phrase: "to K.A.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "M."

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "K.U."

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "supported by a fellowship"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015770:Fellowship [Educational Activity]
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "from the Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology Agency of Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0237463:Agency [Organization]

Phrase: "("

Phrase: "to"

Phrase: "M."

Phrase: "A.A."

Phrase: ")."
Processing 00000000.tx.185: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.186: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.187: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.188: Present address: Dept. of Laboratory Medicine, National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8551,Japan. 

Phrase: "Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Laboratory Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "National Center Hospital for Mental, Nervous"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0020021:Mental hospital [Health Care Related Organization,Manufactured Object]
   753   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   753   C1510665:Hospital [Qualitative Concept]

Phrase: "and"

Phrase: "Muscular Disorders,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026848:Muscular Disorders [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "National Center of Neurology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "Kodaira,"

Phrase: "Tokyo 187-8551,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.189: ** Present address: Dept. of Demyelinating Disease and Aging, National Institute of Neuroscience, Kodaira, Tokyo 187-8502,Japan.  

Phrase: "*"

Phrase: "* Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Demyelinating Disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011303:Demyelinating Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "National Institute of Neuroscience,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Kodaira,"

Phrase: "Tokyo 187-8502,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.190: To whom correspondence should be addressed: Dept. of Neural Plasticity, Tokyo Institute of Psychiatry, 2-1-8Kamikitazawa, Setagaya-ku, Tokyo 156-8585,Japan. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Neural Plasticity,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0027880:neural plasticity [Organ or Tissue Function]
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]

Phrase: "Tokyo Institute of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "2-1-8Kamikitazawa,"

Phrase: "Setagaya-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 156-8585,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.191: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.192: 81-3-3304-5701(Ext. 

Phrase: "81-3-3304-5701"

Phrase: "(Ext."
Processing 00000000.tx.193: 511); 

Phrase: "511"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.194: Fax: 81-3-3329-8035; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "81-3-3329-8035"

Phrase: ";"
Processing 00000000.tx.195: E-mail: kenueda@prit.go.jp. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "kenueda@prit."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0642416:PRIT [Organic Chemical,Pharmacologic Substance]

Phrase: "go.jp."
Processing 00000000.tx.196: Published, JBC Papers in Press, November 6,2001,DOI 10.1074/jbc.M102981200  ABBREVIATIONS The abbreviations used are: A, amyloid /A4-protein; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "November 6,"

Phrase: "2001,"

Phrase: "DOI 10.1074/jbc.M102981200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "A,"

Phrase: "amyloid /A4-protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.197: NAC, non-A component of Alzheimer's disease amyloid; 

Phrase: "NAC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538756:NAC [Gene or Genome]

Phrase: "non-A component of Alzheimer's disease amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.198: NACP, NAC precursor; 

Phrase: "NACP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0285890:NACP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:NACP [Gene or Genome]
  1000   C2983377:NACP [Gene or Genome]

Phrase: "NAC precursor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.199: LB(s), Lewy bodies; 

Phrase: "LB(s"

Phrase: ")"

Phrase: ","

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: ";"
Processing 00000000.tx.200: DLB, dementia with Lewy bodies; 

Phrase: "DLB,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "dementia with Lewy bodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.201: MSA, multiple system atrophy; 

Phrase: "MSA,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "multiple system atrophy"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: ";"
Processing 00000000.tx.202: GCI(s), glial cytoplasmic inclusions; 

Phrase: "GCI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3548440:GCI [Cell Component]

Phrase: "("

Phrase: "s)"

Phrase: ","

Phrase: "glial cytoplasmic inclusions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C3548440:glial cytoplasmic inclusion [Cell Component]
   901   C0205708:Cytoplasmic Inclusions [Cell Component]
   827   C0010834:Cytoplasmic [Cell Component]
   827   C0521449:Cytoplasmic [Body Location or Region]
   793   C1512693:Inclusion [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.203: MAP, microtubules-associated proteins; 

Phrase: "MAP,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "microtubules-associated proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C0026045:Microtubule-Associated Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896   C0026042:Microtubule Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.204: EM, electron microscopy; 

Phrase: "EM,"

Phrase: "electron microscopy"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.205: HPLC, high pressure liquid chromatography; 

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "high pressure liquid chromatography"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0008562:Chromatography, High Pressure Liquid [Laboratory Procedure]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0033095:Pressure [Phenomenon or Process]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0460139:Pressure [Finding]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1306345:Pressure [Functional Concept]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]

Phrase: ";"
Processing 00000000.tx.206: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.207: PIPES, 1,4-piperazinediethanesulfonic acid; 

Phrase: "PIPES,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0071109:PIPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   966 E C1709545:PIPE [Pharmacologic Substance]
   966 E C2828033:Pipe [Manufactured Object]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4-piperazinediethanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.208: BSA, bovine serum albumin; 

Phrase: "BSA,"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.209: FITC, fluorescein isothiocyanate; 

Phrase: "FITC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "fluorescein isothiocyanate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.210: Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine.  

Phrase: "Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl"

Phrase: "]glycine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]
Processing 00000000.tx.211: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.212: Uda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. 

Phrase: "Uda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fukushima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Iwai,"

Phrase: "A.,"

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Otero,"

Phrase: "D."
Processing 00000000.tx.213: A.C, Kondo, J., Ihara, Y., and Saitoh, T. 

Phrase: "A.C,"

Phrase: "Kondo,"

Phrase: "J.,"

Phrase: "Ihara,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.214: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.215: Natl. 

Phrase: "Natl."
Processing 00000000.tx.216: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.217: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.218: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.219: 90, 11282-11286[Abstract] 2. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "11282-11286"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.220: Maroteaux, L., Campanelli, J. 

Phrase: "Maroteaux,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Campanelli,"

Phrase: "J."
Processing 00000000.tx.221: T., and Scheller, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Scheller,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.222: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.223: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.224: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.225: 8, 2804-2815[Abstract] 3. 

Phrase: "8,"

Phrase: "2804-2815"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.226: Jakes, R., Spillantini, M. 

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.227: G., and Goedert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.228: (1994) FEBS Lett. 

Phrase: "(1994"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.229: 345, 27-32[CrossRef][Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "345,"

Phrase: "27-32"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.230: Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H. 

Phrase: "Iwai,"

Phrase: "A.,"

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Ge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538705:GE [Gene or Genome]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Flanagan,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.231: A.R., Kittel, A., and Saitoh, T. 

Phrase: "A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kittel,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.232: (1995) Neuron 14, 467-475[Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuron 14,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "467-475"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.233: Xia, Y., Saitoh, T., Uda, K., Tanaka, S., Chen, X., Hashimoto, M., Hsu, L., Conrad, C., Sundsmo, M., Yoshimoto, M., Thal, L., Katzman, R., and Masliah, E. 

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Saitoh,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Uda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tanaka,"

Phrase: "S."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "Hashimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Hsu,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Conrad,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sundsmo,"

Phrase: "M."

Phrase: ","

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Thal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Masliah,"

Phrase: "E."
Processing 00000000.tx.234: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.235: Alzheimer. 

Phrase: "Alzheimer."
Processing 00000000.tx.236: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.237: 3, 485-494 6. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "485-494 6."
Processing 00000000.tx.238: Polymeropoulos, M. 

Phrase: "Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.239: H., Lavedan, C., Leroy, E., Ide, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.240: E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. 

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stenroos,"

Phrase: "E."
Processing 00000000.tx.241: S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. 

Phrase: "S."

Phrase: ","

Phrase: "Chandrasekharappa,"

Phrase: "S."

Phrase: ","

Phrase: "Athanassiadou,"

Phrase: "A.,"

Phrase: "Papapetropoulos,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Johnson,"

Phrase: "W."
Processing 00000000.tx.242: G., Lazzarini, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lazzarini,"

Phrase: "A."
Processing 00000000.tx.243: M., Duvoisin, R. 

Phrase: "M."

Phrase: ","

Phrase: "Duvoisin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.244: C., Di, Iorio, G., Golbe, L. 

Phrase: "C., Di,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "Iorio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Golbe,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.245: I., and Nussbaum, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.246: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.247: (1997) Science 276, 2045-2047[Abstract/Free FullText] 7. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 276,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "2045-2047"

Phrase: "[Abstract/Free FullText"

Phrase: "] 7."
Processing 00000000.tx.248: Krger, R., Kuhn, W., Mller, T., Woitalla, D., Graeber, M., Ksel, S., Przuntek, H., Epplen, J. 

Phrase: "Krger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Mller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Ksel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J."
Processing 00000000.tx.249: T., Schls, L., and Riess, O. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schls,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.250: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.251: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.252: 18, 106-108[Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "18,"

Phrase: "106-108"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.253: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.254: G., Song, H. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.255: J., and Poo, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Poo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015733:poo [Body Substance]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.256: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.257: (1997) Nature 388, 839-840[CrossRef][Medline] [OrderarticleviaInfotrieve] 9. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 388,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "839-840"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 9."
Processing 00000000.tx.258: Arima, K., Uda, K., Sunohara, N., Hirai, S., Izumiyama, Y., Tonozuka-Uehara, H., and Kawai, M. 

Phrase: "Arima,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1563875:Arima [Organic Chemical,Pharmacologic Substance]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Uda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sunohara,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hirai,"

Phrase: "S."

Phrase: ","

Phrase: "Izumiyama,"

Phrase: "Y.,"

Phrase: "Tonozuka-Uehara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kawai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.259: (1998) Brain Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.260: 808, 93-100[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "808,"

Phrase: "93-100"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.261: Arima, K., Uda, K., Sunohara, N., Arakawa, K., Hirai, S., Nakamura, M., Tonozuka-Uehara, H., and Kawai, M. 

Phrase: "Arima,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1563875:Arima [Organic Chemical,Pharmacologic Substance]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Uda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sunohara,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Arakawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hirai,"

Phrase: "S."

Phrase: ","

Phrase: "Nakamura,"

Phrase: "M."

Phrase: ","

Phrase: "Tonozuka-Uehara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kawai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.262: (1998) Acta Neuropathol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.263: 96, 439-444[CrossRef][Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "96,"

Phrase: "439-444"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.264: Tu, P. 

Phrase: "Tu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532464:TU [Quantitative Concept]
  1000   C2700314:TU [Fish]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.265: H., Galvin, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Galvin,"

Phrase: "J."
Processing 00000000.tx.266: E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. 

Phrase: "E.,"

Phrase: "Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Giasson,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Leight,"

Phrase: "S."

Phrase: ","

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.267: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.268: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.269: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.270: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.271: 44, 415-422[Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "44,"

Phrase: "415-422"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.272: Wakabayashi, K., Yoshimoto, M., Tsuji, S., and Takahashi, H. 

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Tsuji,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.273: (1998) Neurosci. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.274: Lett. 

Phrase: "Lett."
Processing 00000000.tx.275: 249, 180-182[CrossRef][Medline] [OrderarticleviaInfotrieve] 13. 

Phrase: "249,"

Phrase: "180-182"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 13."
Processing 00000000.tx.276: Conway, K. 

Phrase: "Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.277: A., Harper, J. 

Phrase: "A.,"

Phrase: "Harper,"

Phrase: "J."
Processing 00000000.tx.278: D., and Lansbury, P. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.279: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.280: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.281: Med. 

Phrase: "Med."
Processing 00000000.tx.282: 4, 1318-1320[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "4,"

Phrase: "1318-1320"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.283: Wood, S. 

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.284: J., Wypych, J., Steavenson, S., Louis, J. 

Phrase: "J.,"

Phrase: "Wypych,"

Phrase: "J.,"

Phrase: "Steavenson,"

Phrase: "S."

Phrase: ","

Phrase: "Louis,"

Phrase: "J."
Processing 00000000.tx.285: C., Citron, M., and Biere, A. 

Phrase: "C., Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.286: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.287: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.288: Biol. 

Phrase: "Biol."
Processing 00000000.tx.289: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.290: 274, 19509-19512[Abstract/Free FullText] 15. 

Phrase: "274,"

Phrase: "19509-19512"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.291: Hossain, M.S., Alim, M.A., Takeda, K., Kaji, H., Shinoda, T., and Uda, K.(2001) J.

Phrase: "Hossain,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Alim,"

Phrase: "M."

Phrase: "A.,"

Phrase: "Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kaji,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shinoda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Uda,"

Phrase: "K.(2001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.292: Alzheimer. 

Phrase: "Alzheimer."
Processing 00000000.tx.293: Dis. in press 16. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "in press 16."
Processing 00000000.tx.294: Han, H., Weinreb, P. 

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Weinreb,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.295: H., and Lansbury, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.296: T.

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.297: Jr. 

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.298: (1995) Chem. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.299: Biol. 

Phrase: "Biol."
Processing 00000000.tx.300: 2, 163-169[Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "163-169"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.301: Shelanski, M. 

Phrase: "Shelanski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.302: L., Gaskin, F., and Cantor, C. 

Phrase: "L., Gaskin,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Cantor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108263:Cantor [Organic Chemical,Pharmacologic Substance]

Phrase: "C."
Processing 00000000.tx.303: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.304: (1973) Proc. 

Phrase: "(1973"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.305: Natl. 

Phrase: "Natl."
Processing 00000000.tx.306: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.307: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.308: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.309: 70, 765-768[Abstract] 18. 

Phrase: "70,"

Phrase: "765-768"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 18."
Processing 00000000.tx.310: Weingarten, M. 

Phrase: "Weingarten,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.311: D., Lockwood, A. 

Phrase: "D."

Phrase: ","

Phrase: "Lockwood,"

Phrase: "A."
Processing 00000000.tx.312: H., Hwo, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hwo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.313: Y., and Kirschner, M. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Kirschner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.314: W. 

Phrase: "W."
Processing 00000000.tx.315: (1975) Proc. 

Phrase: "(1975"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.316: Natl. 

Phrase: "Natl."
Processing 00000000.tx.317: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.318: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.319: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.320: 72, 1858-1862[Abstract] 19. 

Phrase: "72,"

Phrase: "1858-1862"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 19."
Processing 00000000.tx.321: Ma, J., Yee, A., Brewer, H. 

Phrase: "Ma,"

Phrase: "J.,"

Phrase: "Yee,"

Phrase: "A.,"

Phrase: "Brewer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402217:Brewer [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.322: B., Jr., Das, S., and Potter, H. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
  1000   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.323: (1994) Nature 372, 92-94[CrossRef][Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 372,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "92-94"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.324: Harper, J. 

Phrase: "Harper,"

Phrase: "J."
Processing 00000000.tx.325: D., and Lansbury, P. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.326: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.327: (1997) Annu. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.328: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.329: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.330: 66, 385-407[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "66,"

Phrase: "385-407"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.331: Arima, K., Kowalska, A., Hasegawa, M., Mukoyama, M., Watanabe, R., Kawai, M., Takahashi, K., Iwatsubo, T., Tabira, T., and Sunohara, N. 

Phrase: "Arima,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1563875:Arima [Organic Chemical,Pharmacologic Substance]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kowalska,"

Phrase: "A.,"

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Mukoyama,"

Phrase: "M."

Phrase: ","

Phrase: "Watanabe,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kawai,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tabira,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Sunohara,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.332: (2000) Neurology 54, 1787-1795[Abstract/Free FullText] 22. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurology 54,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1787-1795"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.333: Jensen, P. 

Phrase: "Jensen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.334: H., Islam, I., Kenney, J., Nielsen, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Islam,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022126:Islam [Idea or Concept]

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kenney,"

Phrase: "J.,"

Phrase: "Nielsen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.335: S., Power, J., and Gai, W. 

Phrase: "S."

Phrase: ","

Phrase: "Power,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "J.,"

Phrase: "and"

Phrase: "Gai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517505:GAI [Research Activity]

Phrase: "W."
Processing 00000000.tx.336: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.337: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.338: Biol. 

Phrase: "Biol."
Processing 00000000.tx.339: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.340: 275, 21500-21507[Abstract/Free FullText] 23. 

Phrase: "275,"

Phrase: "21500-21507"

Phrase: "[Abstract/Free FullText"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.341: Takeda, A., Mallory, M., Sundsmo, M., Honer, W., Hansen, L., and Masliah, E. 

Phrase: "Takeda,"

Phrase: "A.,"

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Sundsmo,"

Phrase: "M."

Phrase: ","

Phrase: "Honer,"

Phrase: "W.,"

Phrase: "Hansen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Masliah,"

Phrase: "E."
Processing 00000000.tx.342: (1998) Am. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.343: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.344: 152, 367-372[Abstract] 24. 

Phrase: "152,"

Phrase: "367-372"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 24."
Processing 00000000.tx.345: Mukaetova-Ladinska, E. 

Phrase: "Mukaetova-Ladinska,"

Phrase: "E."
Processing 00000000.tx.346: B., Hurt, J., Jakes, R., Xuereb, J., Honer, W. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hurt,"

Phrase: "J.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Xuereb,"

Phrase: "J.,"

Phrase: "Honer,"

Phrase: "W."
Processing 00000000.tx.347: G., and Wischik, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wischik,"

Phrase: "C."
Processing 00000000.tx.348: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.349: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.350: Neuropath. 

Phrase: "Neuropath."
Processing 00000000.tx.351: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.352: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.353: 59, 408-417[Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "59,"

Phrase: "408-417"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.354: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.355: G., Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.356: A., Jakes, R., Hasegawa, M., and Goedert, M. 

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.357: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.358: Natl. 

Phrase: "Natl."
Processing 00000000.tx.359: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.360: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.361: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0041703:U S [Geographic Area]
Processing 00000000.tx.362: 95, 6469-6473[Abstract/Free FullText] 26. 

Phrase: "95,"

Phrase: "6469-6473"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.363: Hashimoto, M., Hsu, L. 

Phrase: "Hashimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Hsu,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.364: J., Sisk, A., Xia, Y., Takeda, A., Sundsmo, M., and Masliah, E. 

Phrase: "J.,"

Phrase: "Sisk,"

Phrase: "A.,"

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Takeda,"

Phrase: "A.,"

Phrase: "Sundsmo,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Masliah,"

Phrase: "E."
Processing 00000000.tx.365: (1998) Brain Res. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.366: 799, 301-306[CrossRef][Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "799,"

Phrase: "301-306"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.367: Braak, E., Braak, H., and Mandelkow, E. 

Phrase: "Braak,"

Phrase: "E.,"

Phrase: "Braak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.368: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.369: (1994) Acta Neuropathol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.370: 87, 554-567[CrossRef][Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "87,"

Phrase: "554-567"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.371: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.372: G., and Goedert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.373: (1998) Trends. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Trends."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]
Processing 00000000.tx.374: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.375: 21, 428-433[CrossRef][Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "21,"

Phrase: "428-433"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.376: Jensen, P. 

Phrase: "Jensen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.377: H., Hager, H., Nielsen, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hager,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nielsen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.378: S., Hojrup, P., Gliemann, J., and Jakes, R. 

Phrase: "S."

Phrase: ","

Phrase: "Hojrup,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gliemann,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Jakes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.379: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.380: Biol. 

Phrase: "Biol."
Processing 00000000.tx.381: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.382: 274, 25481-25489[Abstract/Free FullText] 30. 

Phrase: "274,"

Phrase: "25481-25489"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.383: McKeith, L. 

Phrase: "McKeith,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.384: G., Galasko, D., Kosaka, K., Perry, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Galasko,"

Phrase: "D."

Phrase: ","

Phrase: "Kosaka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Perry,"

Phrase: "E."
Processing 00000000.tx.385: K., Dickson, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.386: W., Hansen, L. 

Phrase: "W., Hansen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.387: A., Salmon, D. 

Phrase: "A.,"

Phrase: "Salmon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036110:Salmon [Fish]
  1000   C0327949:salmon [Fish]
  1000   C0459210:Salmon [Food]

Phrase: "D."
Processing 00000000.tx.388: P., Lowe, J., Mirra, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lowe,"

Phrase: "J.,"

Phrase: "Mirra,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.389: S., Byrne, E. 

Phrase: "S."

Phrase: ","

Phrase: "Byrne,"

Phrase: "E."
Processing 00000000.tx.390: J., Lennox, G., Quinn, N. 

Phrase: "J.,"

Phrase: "Lennox,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Quinn,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.391: P., Edwardson, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Edwardson,"

Phrase: "J."
Processing 00000000.tx.392: A., Ince, P. 

Phrase: "A.,"

Phrase: "Ince,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.393: G., Bergeron, C., Burns, A., Miller, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bergeron,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Burns,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006434:Burns [Injury or Poisoning]
   966 E C1550619:Burn [Substance]

Phrase: "A.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.394: L., Lovestone, S., Collerton, D., Jansen, E. 

Phrase: "L., Lovestone,"

Phrase: "S."

Phrase: ","

Phrase: "Collerton,"

Phrase: "D."

Phrase: ","

Phrase: "Jansen,"

Phrase: "E."
Processing 00000000.tx.395: N., Ballard, C., de Vos, R. 

Phrase: "N., Ballard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "de Vos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.396: A., Wilcock, G. 

Phrase: "A.,"

Phrase: "Wilcock,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.397: K., Jellinger, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Jellinger,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.398: A., and Perry, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Perry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.399: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.400: (1996) Neurology 47, 1113-1124[Abstract] 31. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neurology 47,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1113-1124"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.401: Goedert, M., Spillantini, M. 

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.402: G., and Davies, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Davies,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.403: W. 

Phrase: "W."
Processing 00000000.tx.404: (1998) Curr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.405: Opin. 

Phrase: "Opin."
Processing 00000000.tx.406: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.407: 8, 619-632[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "8,"

Phrase: "619-632"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2002 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

